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SUMMARY
Women with abnormal vaginal discharge may seek treatment at a Family Planning 
(FP) or Genitourinary Medicine (GUM) clinic. This common problem may also be 
managed in Primaiy Care or at a gynaecology clinic. There is no accepted standard 
strategy in the United Kingdom (UK) for management of this condition. Protocols 
for care have evolved mainly by custom and practice rather than from a frrm 
evidence base.
Although in the UK the specialities of GUM and FP have traditionally been 
organised separately, recently these services have become more integrated in order to 
provide an efficient, patient-orientated approach. In some centres, such as the 
Sandyford Initiative in Glasgow, FP and GUM services are now housed under the 
one roof. This has highlighted the difference in approaches to the management of 
vaginal discharge. The GUM strategy utilises near-patient microscopy of the genital 
specimens and offers an immediate microscopy-based diagnosis. Specimens from the 
FP strategy however, are transferred to the local laboratory for analysis. Using this 
strategy, the clinician will make a presumptive initial diagnosis based on the clinical 
signs and symptoms.
Integration of services at the Sandyford Initiative allowed us the opportunity to 
perform a study comparing the FP and GUM strategies for the management of 
vaginal discharge in terms of diagnostic accuracy. 200 women (100 each from FP 
and GUM) were recruited to, and completed this randomised controlled cross-over 
study. The FP and GUM strategies were performed on all participants. The sequence
in which the strategies were performed was randomised to avoid sampling bias. The 
initial FP diagnosis based on clinical symptoms and signs and the GUM microscopy 
diagnosis were compai'ed with the reference standard of both strategies combined. In 
addition, the final results from both strategies were compared with the reference 
standard. Strategy accuracy was assessed by the difference of two paired 
proportions, together with 95% confidence intervals. Statistical significance was 
assessed by McNemar’s test.
All participants completed the study. The mean age of participant was 28 years 
(range 1 6 - 5 1  years). There were 185 Caucasian participants and 15 participants 
from other ethnic origins. No significant difference was found in age and ethnicity 
when the partieipants from each clinic and each randomised sequence group were 
compared using the Z  test. 132 participants had one sexual partner in the previous 
year. GUM participants had significantly more sexual partners than FP participants 
in the last year (p = 0.005). The number of FP and GUM participants with a previous 
STI was statistically similar (23 and 31 respectively).
There were 140 diagnoses of non-sexually transmitted infections made in the study 
participants. These consisted of 63 cases of Bacterial vaginosis, 60 of Candida 
albicans, and 17 streptococcal infections. Nineteen sexually transmitted infections 
were diagnosed in 19 participants. There were 16 cases of Chlamydia trachomatis, 
two cases of Trichomonas vaginalis and one case of Neisseria gonorrhoea.
This study found that the strategy of near-patient microscopy (GUM) was more 
accurate than best clinical diagnosis (FP), in terms of immediate diagnostic accuracy
(p < 0.001). The FP strategy however, was foimd to be significantly more accurate 
than the GUM strategy in terms of final diagnosis (p = 0.019). This is because the 
GUM strategy did not include a vaginal specimen for culture and therefore missed 
many of the diagnoses of Candida albicans and streptococci. The day 1 GUM 
strategy had a greater sensitivity and specificity than the day 1 FP strategy (72% and 
98% vs. 68% and 59% respectively). The day 7 FP strategy had a greater sensitivity 
and specificity than the day 7 GUM strategy (86% and 100% vs. 75% and 99% 
respectively).
Prior to the introduction o f new practices at the Sandyford Initiative it was 
considered essential to determine the views and needs of our clients. We therefore 
undertook a questiomiaire-based study to assess user views of our service. 200 
participants were questioned regarding various aspects of the GUM and FP clinics 
including access to the service, waiting times and views on the use of near-patient 
testing. When questioned about choice of service, most participants said they would 
prefer to attend an FP or GUM service for their sexual health needs rather than their 
General Practitioner (GP) or a hospital clinic. Although neai-patient testing results in 
a longer time spent in clinic, 99% of participants expressed a preference for 
immediate microscopy results and treatment.
As sexual health services modernise and change in the UK, the traditional roles and 
duties of staff are adapting and expanding. It is vital that staff are equipped with the 
knowledge and skills necessary to competently extend their roles. In recognition of 
their educational needs, FP staff at the Sandyford Initiative were given the 
opportunity to attend the Sexually Transmitted Infections Foundation (STIF) course,
which was developed by the Medical Society for the Study of Venereal Diseases 
(MSSVD).
A study was undertaken to evaluate the educational impact of the STIF course. 16 FP 
doctors and 4 FP nurses were invited to participate in the study, which was designed 
to assess their knowledge of cervical and vaginal infections. The researcher 
administered four clinical case scenarios. Each participant had to make a diagnosis 
based on the patient history and clinical photographs, which were provided. 
Following attendance at the STIF course, the participants were re-tested with the 
initial scenarios. The pre- arrd post-course scores were compared. Statistical analysis 
was performed using one and two sample t-tests and confidence intervals for the 
difference o f two means. There was a mean increase of 2.5 points in all participants’ 
scores. Comparison of pre- and post-course scores revealed a statistically significant 
improvement (p = 0.001).
In sunmiary the studies presented in this thesis were performed in response to the 
changing remit of sexual health services in the UK. The findings of these studies 
have been used to modify and influence practice at the Sandyford Initiative, and 
could be used to implement change in departments offering a similar service.
CHAPTER 1: INTRODUCTION AND AIMS
“Seeing much, suffering much, and studying much, are the tluee pillars of learning.” 
Benjamin Disraeli, Prime Minister of Great Britain, 1874-1880
1.1 General introduction
Many women experience abnormal vaginal discharge at some time in their lives. 
(Hay 1999b). At least 25% of women attending Genitourinary Medicine (GUM) 
clinics receive treatment for one of the tlnee common causes of abnormal vaginal 
discharge: bacterial vaginosis, candidiasis and trichomoniasis. As an alternative to 
GUM services, women with vaginal discharge may choose to attend their General 
Practitioner (GP), or a Family Plaiming (FP) or gynaecology clinic.
The management of women presenting with vaginal discharge varies according to 
the service. There are two main strategies of management in current use in the UK. 
The strategy traditionally utilised in community settings such as Primary Care and 
FP as well as in hospital settings such as gynaecology, is that of Triple swabs’ 
(Figure 1.1.1). This consists of swabs taken from the endocervix and vagina for 
microbiology culture and an endocervical sample for Chlamydia trachomatis testing. 
These specimens are sent to the local laboratories for analysis. Using this strategy, 
the clinician will make a presumptive initial diagnosis based on the clinical signs and 
symptoms and will manage the patient accordingly, whilst awaiting the laboratory 
results. In contrast, GUM services utilise on-site laboratory facilities for near-patient 
microscopy of the genital specimens (Fig 1.1.1). This results in an immediate 
microscopy-based diagnosis.
These strategies have been developed historically and although there is a large 
evidence base for the use of specific diagnostic tests, there is a lack of evidence 
supporting the use of either strategy. Although the role of near-patient microscopy 
has been evaluated within the GUM setting in asymptomatic women, (Andrews et al. 
1994) there are no studies to date that directly compare the accuracy of these 
different strategies in either asymptomatic or symptomatic individuals. No evidence 
base currently exists to confirm that on-site microscopy should be enlisted in the 
management of all women presenting with vaginal dischar ge.
Figure 1.1.1 Current strategies for the diagnosis of vaginal discharge
FP <& GUM Strategies
History and Examination
/ \
FP Strategy (“triple 
swabs”)
•  Vaginal pH
• High vaginal swab in 
Aimes medium*
• Endocervical swab in 
Aimes medium*
GUM Strategy
•  Vaginal pH
Wet mount o f posterior 
vaginal fluid t
• Gram stain o f  lateral 
vaginal wall specim ent
• Endocervical & Urethral 
specimens for Gram
staint & gonococcal 
culture (direct 
inoculation)
FP & GUM strategies
• Endocervical swab for 
Chlamydia trachomatis 
nucleic acid amplification
FP = Family Planning. GUM = Genitourinary Medicine
* These specimens are transported to the local laboratory for: culture on selective and 
non-selective gonococcal agar (incubation for 48 hours at 37"C in 5% CO2), and 
chloramphenical containing Sabarouds medium; incubation in Feinbergs medium for 
48 hours at 37"C and inverted light microscopy; and Gram film and microscopy, 
tThese specimens are examined with on-site microscopy. The inoculated gonococcal 
plates are then transported to the local laboratory for incubation and examination.
1.2 Background to Seivice provision
FP and GUM services were developed separately and on the whole continue to 
evolve independently (Kane & Wellings 1999; Stedman & Elstein 1995). Although 
both services undertake similar work and aim to deliver patient-centred care, they 
still function, as a whole in parallel (Stedman & Elstein 1995; Wilkinson, Hampton, 
& Bradbeer 2000).
GUM services were developed along a medical model in hospital settings. They 
were initially created to meet the needs of army personnel returning from the First 
World War with venereal diseases (VD), (Adler 1980; Adler 1982; Wyke 1973). At 
the beginning of the 20 ’^’ century, the Royal Commission on Venereal Diseases 
produced a document, which led to the Public Health (Venereal Diseases) 
Regulations in 1916 (Royal Commission on Venereal Diseases 1916). This allowed 
for the establishment of specialist clinics for the diagnosis and treatment of STFs. 
The emphasis of these clinics was to provide confidential services, which were free 
of charge. In 1948 at the inception of the National Health Services (NHS), these 
services were brought into hospitals.
In the post World War II era, penicillin dramatically changed the face of VD. The 
incidence of syphilis and gonorrhoea fell to an all time low in the 1950s (Moore J.E. 
1956), allowing those physicians working in VD clinics to concentrate on other 
‘STD’s’. Most venereologists changed their name to genitourinary physicians around 
this time to reflect the change in workload (Birley et al. 2002). The majority of GUM 
departments are today housed in hospital settings and staffed by physicians.
FP services in the UK were initiated with the opening of the first birth control clinic 
in London founded by Marie Stopes in 1921. The first clinics were met with much 
resistance from the medical profession, the church and society in general (Belfield 
2000). Demand for such family planning services however, continued, particularly in 
the light of rising maternal mortality rates. In 1930, the National Birth Control 
Council was formed from the union of separate birth control societies. This was to 
become the Family Planning Association (FPA) in 1939.
It was not until the mid 1970s that family planning services became freely available 
to all by the passing of the NHS reorganisation Act (Belfield 1999; Wilkinson, 
Hampton, & Bradbeer 2000). As a result of this, the FPA clinics were handed over to 
Area Health Authorities and Boards. The structure of the services remained 
substantially different from other primary eare services and from secondary care 
within the NHS, as they provided direct access for women, and were run on a less 
hierarchical basis than was usual in the NHS. To date the majority of FP services are 
based in community settings.
For most of the 20^ *' century, the specialities of GUM and FP continued to evolve in 
parallel. In the early 1990s, there was increased interest in combining and integrating 
the two services. Providers of the services and commissioners realised that the 
traditional separate services offered by GUM and FP were in many ways imperfect. 
Neither speciality offered the entire spectrum of sexual health services in a holistic 
manner, but at the same time there was considerable overlap in service provision. 
The obvious strengths of the GUM service were human immunodeficiency virus 
infection (HIV) and sexually transmitted infection (STI) expertise, with its weakness
being the provision of contraception. FP primarily offered a contraceptive service 
and was predominantly attended by women. Its main weakness was the area of STI 
management (Dawson & Greenhouse 1996).
In 1995, a Consensus Workshop on Sexually Transmitted Diseases and 
Contraception, Sexual Health Promotion and Service Delivery was jointly sponsored 
by the Faculty o f Family Planning and Reproductive Health Care (FFPRHC), the 
Medical Society for the Study of Venereal Diseases (MSSVD) and the Faculty of 
Public Health Medicine, and endorsed by the Association for Genitourinary 
Medicine (Kubba & Randall 1998). This national consensus workshop 
recommended that the services should converge to provide more holistic sexual 
healthcare (Dawson & Greenhouse 1996). This change in service provision would 
offer greater acceptability, convenience and cost effectiveness, whilst avoiding 
service duplication and errors due to clinical ignorance. It was recognised that 
practical constraints might be a barrier to full integration of FP and GUM, and 
therefore as a minimum, it was advocated that collaboration and coordination 
between the two services should occur (Searle 1995).
The first ever National Strategy for Sexual Health and HIV in England was 
published at the end of July 2001 (Department of Health 2001). The strategy has 
recognised the current problems, and wide variations in access to sexual health 
services tlmoughout the UK. One of the key proposals is to ‘evaluate the benefits of 
more integrated sexual health services, including pilots of one-stop clinics’. The 
strategy also defines three levels of service activity with different elements of care
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provided by primaiy care teams, GUM, gynaecology and FP (Adler et al. 2002; 
Robinson & Rogstad 2003).
Convergence of FP and GUM services is becoming more widespread, and the 
number of centres in which they are now housed under one roof has increased over 
recent years (Bloxham, Capstick, & Greenwood 1999; Dawson & Greenhouse 1996; 
Jones 2000; Laughlin et al. 2001). Although it has been recognised that the 
integration process has many challenges (Stedman & Elstein 1995; Wilkinson, 
Hampton, & Bradbeer 2000), much progress has been made across the UK.
1.3 The Sandyford Initiative
The Sandyford Initiative in Glasgow, established in June 2000 is an example of a 
centre offering GUM and FP services under one roof (Laughlin et al. 2001). In 
addition, it houses ‘The Centre for Women’s Health’. This organisation established 
in 1995 aims to promote women’s health in a social model context. Since its 
inception, the Sandyford Initiative has aimed to deliver a ‘joined up’ service, which 
provides client centred care whilst optimising available skills and resources. It was 
recognised that initially the FP and GUM departments at the Sandyford Initiative, 
were functioning in parallel, and were essentially separate organisations in the same 
building. Since it opened, the departments have undergone a gradual process of 
integration.
As part of the integration process, attention was given to the development of unified 
clinical systems and protocols. It was noted that clients could attend the Sandyford
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Initiative with a speeific problem and experience quite different strategies of 
management depending on which department they attended. An area in which this 
was highlighted was the management of women presenting with vaginal discharge. 
At the time of our study, a woman could present to either GUM or FP for 
management of this condition, and different protocols would be followed (Figure 
1.1.1).
The FP strategy is widely used tliroughout General Practice and hospital 
gynaecology departments. A history is taken from the patient followed by clinical 
examination. Our FP protocol includes taking a vaginal sample for pH, although this 
is not always performed in other health care settings. Tlii’ee specimens from the 
genital tract are then collected. These are sometimes laiown as ‘triple swabs’. A 
lateral vaginal wall/posterior vaginal fornix specimen (high vaginal swab) and an 
endocervical specimen are taken and transported in Amies Transport Medium with 
charcoal (Amies 1967) to the local bacteriology laboratory. These specimens are 
plated onto selective and non-selective gonococcal agar (incubation for 48 hours at 
37°C in 5% CO2) for culture. They are also plated onto chloramphenical containing 
Sabarouds medium; incubated in Feinbergs medium for 48 hours at 37^C with 
subsequent inverted light microscopy; and subject to gram film and microscopy. The 
third genital tract specimen is an endocervical swab taken for Chlamydia 
IrachomaUs detection by a nucleic acid amplification technique (NAAT). This 
sample is transported to the local virology laboratory.
The GUM strategy is similar to that utilised in other GUM departments in the United 
Kingdom. The initial parts of the strategy -  history, examination, and vaginal pH -
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ai‘e identical to those performed in the FP strategy. The sample taken for detection of 
Chlamydia trachomatis is also processed in an identical manner. The key difference 
in the strategies is the use by GUM of near-patient laboratory facilities. A wet mount 
of vaginal fluid and samples from the lateral vaginal wall, endocervix and urethra are 
gram stained and examined with microscopy on-site. An additional difference is the 
direct plating of endocervical and uretlii'al samples onto selective and non-selective 
gonococcal agar prior to transport for culture.
We recognised the need to develop an evidence based strategy, which could be 
implemented in both departments in the Sandyford Initiative, and adopted by other 
services managing this condition such as primaiy care and gynaecology settings. We 
therefore undertook a study to directly compare these strategies in terms of 
diagnostic accuracy.
1.4 Aetiology of Vaginal Discharge
The vagina is lined at birth with stratified squamous epithelium, produced in 
response to maternal oestrogen. It is a dynamic ecosystem which is sterile at birth, 
becoming colonised within a few days with a predominantly Gram-positive flora. 
Within a few days of birth the vagina is lined with cuboidal epithelium which 
persists until puberty. The vaginal pH in premenarchal females is approximately 
neutral (pH 7.0). At puberty, the epithelium once more becomes stratified squamous, 
the predominant flora changes to lactobacilii, and the pH decreases to less than 4.5 
(Hay 1999b).
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Normal or physiological vaginal discharge consists o f desquamated epithelial cells 
from the vagina and cervix, mucus from the cervical glands, bacteria, and transudate 
from the vaginal wall. It is white in colour and non-offensive (Table 1.4.1). 
Abnormal vaginal discharge is a non-specific and subjective symptom (Wilson 
2003). If a woman has underlying concerns regarding an STI, she may perceive a 
physiological discharge as abnormal.
Table 1.4.1 Characteristics of vaginal discharge
Colour Consistency Odour Associated
symptoms
Vaginal
pH
Physiological Clear
White
Varies 
(with cycle)
None None 3 .5 -4 .5
Bacterial
Vaginosis*
Grey
Milky
White
Watery
Thin
Profuse
Fishy None > 5 .0
Candida
albicans*
White Thick 
Curd-like
None Itch
Soreness
Swelling
3 .5 -4 .5
Chlamydia
trachomatis*
Mucopurulent 
Blood stained
Thick None PCB
IMB
Abdominal
pain
3.5 - 4.5
Neisseria
gonorrhoeae*
Mucopurulent 
Blood stained
Thick None Abdominal
pain
Dysuria
3.5 -4 .5
Trichomonas
vaginalis*
Yellow Thin
Frothy
Fishy Itch
Irritation
Dysuria
Vaginitis
» 5 . 0
PCB = postcoital bleeding; IMB = intermenstrual bleeding 
* These infections can be completely asymptomatic.
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An abnormal discharge can arise from anywhere in the genital tract, and may be due 
to infective or non-infective causes. Infections may be vaginal or cervical and may 
be sexually or non-sexually transmitted (Table 1.4.2).
Table 1.4.2 Causes of vaginal discharge
Non-infective
• Physiological
• Cervical ectopy
• Foreign bodies
• Contraception related
* Infective, non-STI
• Bacterial vaginosis
• Candida infections
* Infective, STI
• Chlamydia trachomatis
• Neisseria gonorrhoeae
• Trichomonas vaginalis
*The infective causes are in order o f frequency o f occurrence.
Bacterial vaginosis
Bacterial vaginosis (BV) is the most common cause o f vaginal discharge in women 
o f reproductive age (Hay 1999a). The reported prevalence varies from 5% in a group 
o f asymptomatic individuals, to as high as 50% of women in Uganda (Wawer, 
Sewankambo, & Serwadda 1999). It was found in approximately 10%-15% of 
women attending a UK gynaecology clinic (Hay & Taylor-Robinson 1992). In the 
UK, the rates are about 9% in general practice, 15% in pregnant women, 20%-25%
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in women undergoing termination of pregnancy (TOP), and 30% in women 
attending STI clinics (Wilson 2003),
BV is not an STI, although it may be associated with an increased number of sexual 
partners. In a study in the United States, microscopy consistent with BV was found 
in 12% of virgin girls (Bump & Buesching 1988). It is caused by an overgrowth of 
anaerobic bacteria, Gardnerella vaginalis (G. vaginalis) and genital mycoplasmas, 
with reduced or absent lactobacilli (Holst et al. 1987). Known risk factors for BV 
include smoking, vaginal douching and use of an intrauterine device (lUD). The 
prevalence is high among lesbian women. In some women the vaginal flora is in a 
very dynamic state and BV may develop and remit spontaneously within a few days. 
It develops most often around the time of menstruation and resolves mid-cycle, 
suggesting that hormonal influences are important in the control of the vaginal flora 
(Keane, Ison, & Taylor-Robinson 1997).
Approximately 50% of women with BV are asymptomatic. When present, the 
symptom most commonly complained of is copious, malodorous (fishy) discharge. 
The odour is caused by the production of volatile amines by anaerobic bacteria and is 
often worse during menstruation or after intercourse. There is no associated itch or 
soreness of the vulva. On examination, the discharge has a typical milky appearance 
and may be frothy. There is no vulvovaginitis, and the vaginal pH is elevated to as 
high as 7.0. Diagnosis of BV can be made using the Amsel criteria (Amsel et al. 
1983). Three of four composite criteria must be present (Table 1.4.3). Alternatively, 
a Gram-stained vaginal smear can be examined using the Hay/lson criteria or the 
Nugent criteria (Hay 1999b; Nugent, Ki'ohn, & Hillier 1991).
16
Table 1.4.3 Criteria for the diagnosis of BV
Amsel Criteria Criteria used in Sandyford GUM
(At least 3 o f 4 must be present) (At least 2 o f 3 must be present)
•  Thin, white, homogeneous 
discharge
• Offensive (fishy) vaginal 
discharge
• pH o f vaginal fluid >4.5 • pH o f vaginal fluid >5.0
• Clue cells on microscopy
• Release o f fishy odour on adding 
10% potassium hydroxide to 
vaginal fluid*
•  “Intermediate” or “Abnormal” 
pattern o f vaginal flora on gram 
stain (Hay’s criteria)
* W hiff or amine test
Recent studies have shown that a Gram-stained vaginal smear is sensitive and 
specific for the diagnosis o f BV, and may be easier to use than A m sefs criteria 
(Wilson 2003). The Hay/lson criteria are defined as: grade 1 (normal flora); grade 2 
(intermediate flora) and grade 3 (abnormal flora), (Appendix II). The Nugent score is 
derived from estimating the relative proportions o f bacterial morphotypes to give a 
score between 0 and 10. A score o f less than four is normal, four to six is 
intermediate, and greater than six is BV (Hay 1999a). The GUM department at the 
Sandyford Initiative employs a combination o f A m sefs and Hay’s criteria (Table 
1.4.3). The high vaginal swab (HVS) and the endocervical swabs are sent from the 
FP department at the Sandyford Initiative to the local laboratory in Aimes transport 
medium and then Gram-stained and examined with Hay’s criteria (Table 1.4.4). 
Culture o f vaginal secretions is not a useful diagnostic test for BV as 30% - 50% of 
women are colonised with G. vaginalis and anaerobes as part o f their normal vaginal 
tlora (Wilson 2003).
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Table 1.4.4 Diagnosis of specific infections at the Sandyford Initiative
GUM Protocol FP protocol*
Bacterial Vaginosis
Sample Lateral vaginal wall Lateral vaginal wall
Laboratory On-site Local bacteriologyTechnique Hay’s criteria on Gram- Endocervical swab and
stain HVS in Aimes. Gram- 
stained for microscopy. 
Hay’s criteria
Candida albicans
Sample Lateral vaginal wall Lateral vaginal wall
Laboratory On-site Local bacteriologyTechnique Gram-stain Endocervical swab and 
HVS in Aimes. Gram- 
stained for microscopy & 
plated onto Sabouraud’s 
medium for culture
Chlamydia trachomatis
Sample Endocervical swab Endocervical swab
Laboratory Local virology Local virologyTechnique LCR* LCR*
Neisseria gonorrhoeae
Sample Endocervical, urethral Endocervical
Laboratory On-site and local Local bacteriologyTechnique Microscopy of Gram- Endocervical swab and
stain & direct inoculation HVS in Aimes. Delayed
onto GC selective and inoculation onto selective
non-selective agar. & non-selective GC agar.
Transported to local 
laboratory. 48 hour 
incubation.
48 hour incubation.
Trichomonas vaginalis
Sample Posterior vaginal fornix Posterior vaginal fornix
Laboratory On-site Local bacteriologyTechnique Wet mount microscopy Endocervical swab and
(0.9% saline) HVS in Aimes. Cultured 
in Feinbergs medium 
(48hrs at 37"c), and 
inspected by inverted light 
microscopy
LCR= ligase chain reaction; HVS= high vaginal swab; GC = gonococcus 
* LCR has now been withdrawn because of the risk of false positive results. The current test 
in use at the Sandyford Initiative is strand displacement assay (SDA).
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Treatment of BV is recommended for all symptomatic women, those undergoing 
gynaecological surgery (including TOP), and pregnant women with a previous 
preterm birth (Hay 1999a). Treatment is usually in the form of metronidazole tablets 
(400mg twice daily for 5 - 7  days), but alternatively, metronidazole suspension (2g 
stat), or intravaginal clindamycin cream (2%) can be prescribed. All these treatments 
have been shown to achieve cure rates of 70% - 80% after four weeks in controlled 
trials (Hay 1998; Hillier et al. 1993; Larsson 1992; Lugo-Miro, Green, & Mazur 
1992) . Treatment of sexual partners has not been shown to decrease the recurrence 
rates and therefore is not required (Colli, Landoni, & Paiazzini 1997).
Candidiasis
It is estimated that 75% of women will experience at least one episode of 
symptomatic vaginal candidiasis in their lifetime. Fortunately for most women it 
responds to simple treatments, however, 40% - 50% will have a further episode. 
There is a 15% - 20% point prevalence of asymptomatic Candida carriage in young, 
non-pregnant, premenopausal women (Bingham 1999). In 80% - 92% of cases the 
causative agent is Candida albicans. The remainder aie caused by Candida glabrata 
and other species (Daniels & Forster 1999). There are a number of recognised 
predisposing host factors for genital candidiasis, wliich affect either local or systemic 
immunity, and encourage Candida to become symptomatic. These factors are 
pregnancy, diabetes, immunosuppression, antimicrobial therapy and vulval 
irritation/trauma (Hay 1999b). The cyclical nature of symptoms in those women with 
recurrent infections, and the rarity of Candida infections premenarche and 
postmenopausally, suggest a sex hormone dépendance (Wilson 2003). Although use 
of the older ‘high oesti'ogen dose’ combined oral contraceptive pills may have been
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associated with candidiasis, no association has been shown with use of cunent low 
dose oestrogen preparations (Davidson & Oates 1985). Men can be colonised with 
Candida however, it is not recognised as an STI. There is no evidence to support 
treatment of asymptomatic male sexual partners, and this has not been shown to 
reduce recurrent infections (Bisschop et al. 1986).
Women with Candida infections most commonly complain of vulval or vaginal itch. 
This is accompanied by the typical curdy white discharge in about 50% of women. 
The discharge is non-offensive. Other symptoms include soreness of the vulva, 
external dysuria and superficial dyspareunia. On examination, there may be vulval 
oedema, eiythema, and fissuring. The typical white plaques of discharge adhering to 
the vaginal walls may be seen (Daniels & Forster 1999). The vaginal pH is within 
normal limits (4.0 - 4.5). A Gram-stain of vaginal discharge collected from the 
lateral vaginal wall looking for spores or pseudohyphae may detect 65% of 
symptomatic cases (Somiex & Lefort 1999) (Appendix II). The sensitivity of a wet 
mount slide (saline microscopy) of vaginal discharge is 40% - 60% (Sobel 1997). 
Direct inoculation onto Sabouraud’s medium is the most sensitive diagnostic 
method, and if cultur e plates ar e not available for direct plating, the vaginal swab can 
be placed in Aimes or Stuart’s medium for transport and delayed inoculation. 
Sabouraud’s medium supports the growth of all clinically important yeasts. Culture 
has a sensitivity of 70% - 80% and a specificity of greater than 99% (Sobel 1997; 
Wilson 2003). The current method for the diagnosis of Candida infections in the 
Sandyford Initiative GUM department is a gram stained vaginal wall slide. In the FP 
department, culture by means of delayed inoculation of the HVS and endocervical
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swab onto Sabouraud’s medium is routinely employed (Figure 1.1.1 and Table 
1.4.4).
Management of vulvovaginal candidiasis should begin with general advice regarding 
the avoidance of wearing tight fitting synthetic clothing and use of local iiTitants 
such as perfumed soaps and bubble baths (Daniels & Forster 1999). Many antifungal 
preparations are available for the treatment of Candida, all with efficacies of 80% - 
90%. A Clotrimazole 500mg pessaiy is the treatment of choice at the Sandyford 
Initiative, with an alternative being a single oral dose of fluconazole 150mg. A UK 
study showed that approximately 50% of women preferred oral treatment (Tooley 
1985), however these therapies are contraindicated in pregnancy. Sexual partners do 
not need treatment unless they also have typical symptoms of Candida.
Chlamydia trachomatis
Chlamydia trachomatis infection is common, affecting 3% - 5% of sexually active 
women attending UK general practice (Department of Health 1998; Stokes 1997). 
The second National Survey of Sexual Attitudes and Lifestyles (Natsal 2000) found 
a chlamydia prevalence of 2.2% in men and women aged 1 6 - 4 4  years and a 
prevalence of 3.0% in women aged 1 8 - 2 4  years (Fenton et al 2001). Community 
chlamydia screening pilot studies involving women less than 25 years in Portsmouth 
and the Wirral have found higher rates of infection (approximately 10%) (Tobin, 
Harindra, & Tucker 2000; Wilson 2003). In 2003 there were 2006 diagnoses of 
female genital chlamydia infection in Greater Glasgow (440.31/100,000 female 
population) and 9199 female cases in Scotland (350.71/100,000 female population).
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Complications cost at least £50 million amiually in the UK and therefore this 
infection is considered to be a serious public health issue (Taylor-Robinson 1994),
Chlamydia is a sexually transmitted disease in adults with approximately 60% - 70% 
of sexual partners being infected. The primary site of infection in women is the 
cervix, with the uretlna also being infected in about 50% of cases. The rectum and 
the pharynx may less commonly be infected. Risk factors for infection include; age 
less than 25 years, new sexual partner or more than one sexual partner in the recent 
year’s, lack of bar rier contraception, and use of the oral contraceptive pill (Horner & 
Caul 1999). Women undergoing termination of pregnancy also appear to be at 
increased risk. Knowledge of these risk factors has aided the introduction of 
chlamydia screening programmes and pilot schemes tlrroughout the UK.
Approximately 80% of women with Chlamydia trachomatis infection are 
asymptomatic. The remainder may complain of purulent vaginal discharge, 
postcoital or intermenstrual bleeding, lower abdominal pain or dysuria. On 
examination the cervix may look normal, but there may be a mucopurulent cervicitis 
and contact bleeding (Horner & Caul 1999). Chlamydial diagnostics continue to be a 
rapidly developing field. As Chlamydia trachomatis is an intracellular bacterium, it 
can only be grown in cell culture. Although culture is highly specific (100%), it has a 
comparatively low sensitivity of 40% - 85% and therefore is not used in routine 
practice except for medico-legal cases. Other methods including enzyme 
immunoassay (ElA) and direct fluorescent antibody (DFA) detection are being 
replaced by NAAT’s. Levels of detection can be increased to over 90% by use of a 
NAAT, which is more sensitive than culture, EJA, or DFA. An additional advantage
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of a NAAT is that a first void mine sample can be used instead of an endocervical 
swab (SIGN 2000). At the time of our study, both the GUM and FP departments at 
the Sandyford Initiative were testing for Chlamydia trachomatis in women with 
vaginal discharge by means of an endocervical swab sent to the local virus 
laboratory for ligase chain reaction (LCR), (Figure 1.1.1, Table 1.4.4).
Recommended treatments for uncomplicated chlamydial infection are oral 
doxycycline lOOmg twice daily for one week, or azithromycin Ig as a single dose. 
The former is less expensive, however azithromycin is recommended if poor 
adherence is suspected (Horner & Caul 1999). In pregnancy, erythromycin or 
amoxycillin should be used as doxycycline is contraindicated, and the safety of 
azithromycin has not yet been fully assessed. Patients should be told to abstain from 
sex until they and their partners have completed treatment. It is recommended that 
partner notification (contact tracing) take place in order to prevent re-infection. A 
test of cure is not required after completed treatment with doxycycline or 
azithromycin as both are highly efficacious. A test of cure should be considered after 
treatment with erytlrr omycin. This test should be postponed for 3 weeks after the end 
of treatment. If taken earlier it may detect non-viable organisms or miss late failures 
(Horner & Caul 1999).
Gonorrhoea
Gonorrhoea is a sexually transmitted infection caused by the Gram-negative 
diplococcus Neisseria gonorrhoeae. There has been a rise in infection rates in the 
UK over the past few years, particularly in women aged between 15-19 years. In 
England over the past 6 year’s, new cases of gonorrhoea have increased by 86%
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(Alder 2003). There were 37 episodes of female gonorrhoea reported in Greater 
Glasgow in 2003 (8.12/100,000 female population). Overall in Scotland there were 
156 episodes reported in women in 2003 (5.95/100,00 population). The Department 
of Health has set a target of a 25% reduction in gonorrhoea infections by 2007 
(Department of Health 2001). Transmission of the infection is by direct inoculation 
of secretions from one mucous membrane to another. Between 60% - 80% of sexual 
partners will also be infected. The primary site of infection in women is the cervix, 
but the urethra is also infected in 70% - 90% of cases (Wilson 2003), Co-infection 
with Chlamydia trachomatis occur s in up to 40% of women (Bignell 1999). Women 
taking the combined oral contraceptive pill (COCP) may be more vulnerable to 
gonorrhoea as the amount of columnar epithelium on their ectocervix is increased. 
Barrier methods of contraception protect against acquisition.
In up to 50% of women infection is asymptomatic. The most common symptom is 
increased or altered vaginal discharge (up to 50%). In addition, women may 
complain of lower abdominal pain (up to 25%), dysur ia, postcoital or inter-menstrual 
bleeding (Bignell 1999). Neisseria gonorrhoeae may co-exist with other genital 
mucosal pathogens, such as Tiichomonas vaginalis^ Candida albicans and 
Chlamydia trachomatis. These pathogens may in fact be responsible for symptoms if 
present. On examination, there may be mucopurulent endocervical discharge which 
may be blood stained. Contact bleeding of the cervix may be easily induced. Pelvic 
or lower abdominal tenderness may be elicited (Barlow & Philips 1978). The ‘gold 
standard’ method of diagnosis of Neisseria gonorrhoeae is culture. This method 
offers a sensitivity of greater than 95%, and is readily available and inexpensive. It 
also allows antimicrobial sensitivity testing. In womerr it is recommended that
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specimens be taken from both the methra and endocervix. If an endocervical swab 
alone is taken then only 85% of cases of infection will be detected. Selective culture 
media containing antimicrobials are often used to reduce contamination (Jephcott 
1997). If facilities for direct inoculation are not available, specimens may be 
transferred to the laboratory in a transport medium such as Aimes. Direct plating of 
media and use of transport media both give acceptable results (FitzGerald & Bedford 
1996). The isolation rate after transport in medium at room temperature is 
approximately 100% within 12 hours, and more than 90% within 24 hours, although 
the number of colonies decreases markedly (WHO 1999). In addition to culture, 
microscopy of a Gram-stained smear of the uretlnal and cervical swabs can be 
performed. This allows direct visualisation of Neisseria gonorrhoeae as 
monomorphic Gram-negative dipiococci within polymoi-phonuclear leukocytes 
(Appendix II). In women the sensitivity of microscopy of Gram-stained endocervical 
smears is 37% - 50% and urethral smears is 20% (Barlow & Philips 1978). In the 
Sandyford Initiative GUM department, specimens are routinely collected from the 
uretlna and cervix. Microscopy is performed on-site and the specimens are directly 
inoculated onto selective and non-selective gonococcal culture plates for incubation. 
Rectal and phaiyngeal specimens aie taken if indicated (e.g. sexual assault). In the 
FP department, the HVS and endocervical swabs are transported in Aimes medium to 
the local laboratory for microscopy of the Gram-stained specimens and culture on 
selective and non-selective gonococcal agar (Figure 1.1.1, Table 1.4.4).
First line antimicrobial treatment for infection with Neisseria gonorrhoeae is under 
regular review in the light of evolving patterns of resistance. The chosen regimen 
should eliminate infection in at least 95% of those presenting in the local community
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(FitzGerald & Bedford 1996). Treatments for uncomplicated genital infection ai*e 
ciprofloxacin 500mg as a single oral dose or ofloxacin 400mg as a single oral dose 
or ampicillin 3g plus Ig of probenacid as a single oral dose (only where regional 
prevalence of penicillin resistant N. gonorrhoeae is <5%) (Bignell 1999). Pregnant 
women should not be treated with quinolone or tetracycline antimicrobials. 
Ceftriaxone 250mg or cefotaxime 500mg by intramuscular injection can be used in 
this situation. At the Sandyford initiative, all women diagnosed with Neisseria 
gonorrhoeae are simultaneously screened and treated for chlamydia infection due to 
the high rate of co-existence. Paitner notification is cairied out, and all patients are 
asked to abstain from sex until they and their partner(s) have been treated. Patients 
are reviewed 14 days after their initial treatment and repeat slides and cultures are 
performed at all previously positive sites.
Trichomonas vaginalis
Prevalence of the infection Trichomonas vaginalis has decreased in the UK over the 
past 15 years. However, in other parts of the world in particular Africa and Asia, the 
infection remains a major cause of vaginal discharge (Wilson 2003). There were 73 
diagnoses of female trichomoniasis made in Scottish GUM clinics in the year up to 
31 March 1999. Trichomonas vaginalis is a flagellated protozoon, 1 0 - 2 0  pm in 
diameter. In women the organism is found in the vagina, urethia and paraurethral 
glands. Although urethral infection is present in about 90% of episodes, it is the sole 
site of infection in less than 5% of cases. In adults tiansmission is almost exclusively 
sexual (Sherrard 1999). Due to site specificity, infection can only follow intravaginal 
or intraurethral inoculation of the organism. There is an increased cure rate in 
women when their sexual partners are treated. Trichomonas vaginalis is associated
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with other STI’s such as gonorrhoea and chlamydia. Women are the main carriers of 
the infection. Some men seem to be able to clear the organism without treatment. In 
one study. Trichomonas vaginalis could be found in 70% of men within 48 hours of 
intercourse with an infected woman and in only 33% after two weeks (Weston & 
Nicol 1963).
Infection in women is asymptomatic in 10% - 50% of cases. If symptoms are 
present, a yellow vaginal discharge is the most commonly experienced. About 50% 
also complain of offensive odour due to amine production by anaerobic bacteria. 
Vulval pruritus occurs in 25% - 50% of women and can sometimes be severe. 
External dysuria and superficial dyspareunia may also be present. Occasionally the 
presenting complaint is of lower abdominal discomfort (Wolner-Hanssen, Kreiger, & 
Stevens 1989). Examination findings reflect the acute inflammatory response that 
trichomoniasis produces. Vulvitis with vulval oedema and excoriation are seen in 
10% - 30% of women. Vaginal discharge will be seen in up to 70% of women. The 
commonly described yellow-green, thin, frothy discharge is evident in less than 50% 
of women. More frequently, the discharge has a grey colour. Approximately 2% of 
women will have the ‘strawberiy cervix’ appearance to the naked eye. This is due to 
punctate haemorrhages. This appearance is more commonly seen at colposcopic 
examination. Up to 15% of women will have no abnormalities seen on examination 
(Sherrard 1999). The vaginal pH is usually raised to between 4.5 - 7.0. Microscopy 
of a wet-mount smear or acridine orange slide from the posterior vaginal fornix will 
diagnose 40% - 80% of cases. Experienced observers can recognise non-motile 
organisms, but it is usually the movement of the flagellae which leads to the 
identification of the trichomonads. An increased number of polymorphonuclear
27
leukocytes is usually also observed. Culture media such as Fineberg-Whittington or 
Bushby allow optimal growth of the organism. This method is more sensitive than 
microscopy and will diagnose up to 95% of cases in women (Bickley et al. 1989). If 
culture medium is not available for direct inoculation, a vaginal swab can be placed 
in Aimes or a similar transport medium. Studies have shown no significant 
difference in sensitivity between delayed and immediate inoculation methods 
(Beverly et al. 1999; Schwebke, Venglarik, & Morgan 1999). Polymerase chain 
reaction (PGR) based diagnostic tests have recently been developed and sensitivities 
and specificities approaching 100% have been reported (Madico et al. 1998). This 
teclmique is still not widely available. Trichomonads are sometimes reported on 
cervical cytology, but there is a false positive rate of about 30% therefore the 
diagnosis should be confirmed by cultiue. The GUM department at the Sandyford 
Initiative employs on-site wet-mount microscopy for routine diagnosis of 
Trichomonas vaginalis (Appendix II). Culture is available at the local laboratory, but 
this is not a routine test in GUM. In the FP department, the HVS and endocervical 
swabs are transported in Aimes medium to the local laboratory where they are 
incubated in Feinbergs medium for 48 hours at 37®c, and inspected by inverted light 
microscopy (Figme 1.1.1, Table 1.4.4).
Most strains of Trichomonas vaginalis are sensitive to metronidazole and other 
imidazole antibiotics. A single 2g dose of oral metronidazole suspension can be 
given. This results in an 80% - 85% cure rate which increases to 95% with 
simultaneous treatment of sexual partners. Alternatively, oral metronidazole 400mg 
twice daily can be given for five to seven days. Partner notification is recommended 
and abstinence from sex should be advised mitil treatment is completed in both
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partners. As 30% of women with Trichomonas vaginalis will also have either 
gonorrhoea or chlamydia a frill STI screen should be performed (Sherrard 1999).
Other causes of vaginal discharge
Abnormal discharge may be associated with the presence of a foreign body, such as 
a retained tampon or fragments of condoms. Women using the lUD for contraception 
may complain of watery or mucoid discharge. Infection should be excluded 
(especially BV), and the woman can then be reassured. The low dose COCP does not 
usually affect vaginal discharge, however cervical ectopy is more likely to occur in 
women using this method of contraception, and this may account for increased 
vaginal discharge. Cervical ectopy is the term applied to a red area on the ectocervix 
which surrounds the external os: this abnormality is often erroneously called an 
‘erosion’. An ectopy is a physiological change consequent upon an increase in 
cervical bulk, as occurs at puberty or in pregnancy; this causes an unfolding of the 
cervix with eversion of the distal endocervix out into what is anatomically the 
ectocervix. The thin endocervical columnar epithelium is relatively transparent and 
hence the subepithelial vessels impart to an ectopy its characteristic redness. The 
exposui’e of the delicate endocervical epithelium to the acidity of the vagina results 
in squamous metaplasia, a protective mechanism (Fox & Elston 1992). Some women 
with cervical ectopy produce an excessive amount of mucus and will often describe 
their discharge as ‘thick and stringy’. Infection should always be excluded in these 
women. The patient can then be reassured or offered treatment with cryotherapy or 
diathermy provided there is a normal cervical smear history. Lancefield group A and 
B streptococci are uncommon causes of vaginitis. Approximately 50% of women 
with group B infection report symptoms of vaginal irritation and soreness. Group A
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infection is less common, but more likely to produce symptoms. There is often a 
marked vaginitis and a serosanguineous discharge (Sonnex 1996b).
1.5 Aims
The provision of sexual health services in the UK is evolving. Integration of service 
providers such as FP and GUM is occurring and greater links with primary care 
teams aie being encouraged. To ensure that resources are effectively utilised and that 
evidence based, patient-centred care is delivered, common guidelines for patient 
management should be introduced. In addition to developing an evidence base for 
new conunon strategies of care, it is vital that users of the service are consulted prior 
to implementation of change, and that their views are taken into account. As sexual 
health services change, the role of staff working in these departments will also 
change. It is important that staff working in the field of sexual and reproductive 
health care aie equipped with the practical skills and knowledge required to 
implement their new roles with confidence.
The studies presented in this thesis were carried out to meet the above challenges. 
The first study compares the current strategies in use at the Sandyford Initiative for 
the management of women with vaginal discharge in FP and GUM. This study was 
undertaken in order to develop a common evidence based strategy that could be used 
in our centre and in other departments providing this service. The second study 
evaluates user views of the sexual health seiwices provided at the Sandyford 
Initiative. The final study was undertaken to assess the knowledge of FP staff prior 
to, and following attendance at the Sexually Transmitted Infections Foundation
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(STIF) Course. FP staff were given the opportunity to attend this course with the aim 
of equipping them with knowledge for the effective management of STFs.
In summary, this thesis aims to address the following questions:
• Which strategy for the management of vaginal discharge is more accurate in 
terms of diagnosis - FP or GUM?
• What are the Sandyford Initiative users views of the GUM and FP services?
• Does attendance at the STIF course improve the knowledge of FP nurses and 
doctors?
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CHAPTER 2: A RANDOMISED CONTROLLED CROSS-OVER STUDY OF 
THE STATEGIES FOR THE MANAGEMENT OF WOMEN WITH  
VAGINAL DISCHARGE IN FAMILY PLANNING AND GENITOURINARY  
MEDICINE.
2.1 Introduction
Women suffering from abnormal vaginal discharge may present to a FP, GUM or 
gynaecology clinic or to their General Practitioner (GP). Abnormal vaginal discharge 
is a common problem and may be due to infective or non-infective causes (Hay 
1999b), (Chapter 1, Table 1.4.2). Currently, there is no accepted standard strategy 
employed for the management of women with vaginal discharge in different health 
care settings. The main strategies in use in the UK can be broadly categorised into 
two groups (Chapter 1, Figure 1.1.1). Women attending their GP, FP or 
gynaecology clinic will have genital samples taken (‘triple swabs’), which are 
transported to the local laboratories (microbiology and virology) for analysis. The 
clinician will often make a presumptive diagnosis based on the available clinical 
information, and may treat the patient accordingly. The laboratory diagnosis will be 
available in approximately seven days. In contrast, the strategy employed in most 
GUM settings in the UK is that of near-patient microscopy of the genital specimens. 
The patient attending this health care setting will receive initial results and treatment 
based on the microscopy findings. The cultiue plates for Neisseria gonorrhoeae are 
subsequently transferred to the local microbiology laboratory for incubation, and the 
chlamydia swab is transferred to the virology laboratoiy. These results are available 
in approximately seven days.
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Recently in the UK concerns have been expressed regarding inadequate provision of 
sexual health care. The House of Commons Health Select Committee has highlighted 
this major public health problem in the published enquiry on sexual health (House of 
Commons Health Select Committee 2003). GUM departments are under increasing 
pressure, and attendance at these clinics in England has doubled over the past 10 
years (Adler 2003). Development of ‘managed service networks’ as recommended 
by the English National HIV and Sexual Health Strategy (Department of Health 
2001) will help meet some of this increased demand by increasing service provision 
by primary care teams. In addition, expansion of consultant posts in GUM and an 
increase in resources have been recommended (House of Commons Health Select 
Committee 2003). These changes alone will not ftilfil all requirements, and therefore 
many GUM departments in the UK are assessing means in which current practices 
can be modified in order to optimise resources. One such aiea where change is being 
considered is routine near-patient microscopy (Robinson & Rogstad 2003). 
Conventionally this is offered to all GUM attendees, and is deemed superior to 
delayed diagnosis using swabs. There have been no studies however to validate this 
assumption. The role of near-patient microscopy has been evaluated within the GUM 
setting in asymptomatic women (Andrews et al. 1994). This study by Andrews et al 
performed in a GUM department in Birmingham concluded that a policy of selective 
microscopy did not lead to any significant delay in the diagnosis and treatment of 
patients with STIs, and was beneficial in terms of more efficient utilisation of 
manpower and resources. There are however no studies to date that directly compare 
the accuracy of the FP and GUM strategies in either asymptomatic or symptomatic 
individuals. No evidence base currently exists to confirm that on-site microscopy
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should be enlisted in the management of all women presenting with vaginal 
discharge.
The Sandyford Initiative in Glasgow is an example of a centre offering both GUM 
and FP services. It is part of the local primary care trust. The centre was established 
in June 2000 and a main objective since its inception has been to improve integration 
of the FP and GUM services. At the time of the study, there was no common strategy 
for the management of women with vaginal discharge. Women with this problem 
could present to either clinic and be managed by different approaches. This study 
was therefore performed to provide an evidence base for the development of a 
strategy that could be implemented in both the FP and GUM clinics in our centre, 
and employed by other similar services.
The study was designed to assess which strategy performed better in terms of 
diagnostic accuracy. Firstly, the strategy of initial diagnosis based on clinical 
symptoms and signs (day 1 FP diagnosis) and the strategy of near-patient 
microscopy (day 1 GUM diagnosis) were compared with the reference standard of 
both strategies combined. Secondly the final laboratory results from the two 
strategies (day 7 diagnoses) were compared with the reference standard.
2.2 Materials and methods
200 women attending the Sandyford Initiative GUM and FP clinics with the primary 
complaint of vaginal discharge were invited to paiticipate in this study. 100 
participants were recruited from each clinic between December 2001 and June 2002.
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Suitable participants were identified at the clinic reception desk using a tick sheet. A 
tick sheet was already in use at the FP reception desk, in order to guide clients to the 
service they required such as contraception or pregnancy counselling. For this study, 
the tick sheet was modified to include ‘vaginal discharge’ as an option. A similar 
sheet was introduced at the GUM reception desk. Participants underwent the study 
protocol in the clinic they had presented to.
Patients were deemed suitable for inclusion in the study if they were aged greater 
than 16 years, with a primary symptom of vaginal discharge and were willing to 
participate. Exclusion criteria comprised: cuiTent participation in other research 
projects, inability to give informed consent, antibiotic therapy within preceding four 
weeks, pregnancy, systemic illness, genital ulceration, Icnown contacts of sexually 
transmitted infeetions and clients attending due to sexual assault.
A randomised controlled cross-over design was used (Figure 2.2.1). Each participant 
was consented for the study and then a clinical history was taken followed by a 
questionnaire. Demographic data was collected using a standard proforma. A single 
researcher (CM) performed all consultations and examinations. Each participant then 
underwent both the FP and GUM strategies in a randomised order. The sequenee in 
which the strategies were performed was determined using randomly allocated 
numbers within independently sealed envelopes. Participants were randomised to 
either GUM strategy first or FP strategy first. Equal numbers of participants were 
randomly allocated to each sequence group (Figure 2.2.1). Subsequent to the 
examination, the reseai’cher documented a diagnosis based on the clinical symptoms 
and signs (day 1 FP diagnosis). Meanwhile, the microscopy slides were prepared
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and examined by the duty Medical Laboratory Scientific Officer (MLSO) in the on­
site GUM laboratory. This microscopy result provided the day 1 GUM diagnosis. 
The reseai’cher was blinded to the microscopy-based diagnosis until the day 1 
diagnosis from the FP strategy had been documented. Equally, the MLSO 
performing the microscopy was blinded to the clinical (FP) diagnosis until the day 1 
GUM diagnosis was documented. To prevent sub-optimal treatment, day 1 
management of each participant was based on the microscopy findings (day 1 GUM 
strategy diagnosis). The FP swabs and the GUM selective and non-selective 
gonococcal culture plates were then transferred to the local microbiology laboratory 
and the chlamydia swab was tiansferred to the virology laboratoi-y. At the time of the 
study, the FP and GUM specimens were being analysed in two different 
microbiology laboratories. For the purposes of the study we obtained permission to 
have all specimens analysed in the same microbiology laboratory (Glasgow Royal 
Infirmary). On day 7, the participants were contacted with their final results, and 
offered further treatment if  required. The questiomiaire was completed during this 
telephone consultation. To determine strategy accuracy, day 1 and 7 diagnoses were 
compared with the reference standard of both strategies combined (Box 2.2.1).
This study received approval from the Greater Glasgow Primary Care Trust 
Research Ethics Committee.
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Figure 2.2.1 Study protocol
GUM participants 
(n=100)
FP participants 
(n=100)
Total participants (n=200)
IFlistoiy and questionnaire 
Randomised to sequence groups
FP then GUM strategy 
(11= 100)
GUM then FP strategy 
(n=100)
Day 1 diagnoses 
FP -  clinical 
GUM -  microscopy
Specimens to laboratory
Day 7 diagnoses 
FP and GUM
Specimens to laboratory
i ÎCompared with reference standard
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Box 2.2.1 -  The reference standard
On-site Gram stain and microscopy o f vaginal, endocervical 
and urethral specimens.
On-site microscopy o f vaginal wet mount (0.9% saline). 
On-site inoculation o f selective and non-selective 
gonococcus agar (endocervical and urethral specimens) for 
culture.
High vaginal and endocervical swabs transported in Aimes 
medium to local laboratory and; Gram stained for 
microscopy; cultured on Sabouraud’s medium; cultured in 
Feinbergs medium; and cultured on selective and non- 
selective gonococcus agar.
Endocervical swab for Chlamydia trachomatis (Nucleic 
acid amplification technique).
Statistics
The study power was set at 80% to detect a 10% difference in strategy veracity rates. 
Strategy accuracy was estimated by the difference o f two paired proportions, 
together with 95% confidence intervals. Statistical significance was assessed by 
McNemar’s test. Statistical comparison o f FP and GUM participants and the 
randomised sequence groups was made using tests and Wilcoxon tests.
Data collection and coding
Data were collected and stored anonymously in a secure SPSS database using a 
study number. Once the final results were obtained for each participant, the 
diagnostic data were coded. If a strategy obtained only one o f the diagnoses in a 
participant with multiple diagnoses or misdiagnosed an infection then it was coded 
as either false positive or false negative. All false positives and negatives were 
combined to give a total number o f incorrect diagnoses. Similarly, to be coded as a
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correct diagnosis, the diagnoses made by the strategy in question had to completely 
agree with the diagnoses made by the reference standard (true positive or true 
negative). This method of data coding produced a total of 200 correct and incorrect 
diagnoses, despite some participants having multiple diagnoses.
2.3 Results
Characteristics of study participants
All participants completed the study. Table 2.3.1 describes the characteristics of all 
study participants, and those participants from FP and GUM. Characteristics and 
comparison of the participants in each randomised sequence group are shown in 
Table 2.3.2. The mean age of participant was 28 years (range 16- 51  years). There 
were 185 white participants and 15 participants from other etluiic origins. No 
significant difference was found in age and ethnicity when the participants from each 
clinic and each randomised sequence group were compared using the test. 132 
participants had one sexual partner in the previous year. Statistical comparison of the 
number of sexual partners in FP and GUM participants showed that GUM 
participants had significantly more sexual partners in the last year (p = 0.005). 
Compai’ison of the number of sexual partners in the randomised sequence groups 
showed no significant difference. Approximately one quarter of paificipants had a 
history of a previous STI (n = 54). 32 of the participants had a history of Chlamydia 
trachomatis^ 25 of genital wart infection (human papilloma virus), 5 of gonorrhoea, 
4 of genital Herpes Simplex virus (HSV) and 1 of Himian Inuminodeficiency Virus 
(FIIV) infection (FP participant). The number of FP and GUM participants with a 
previous STI was statistically similar, and the randomised sequence groups showed 
no difference. The COCP was the most commonly used method of contraception in
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all (n= 95) and GUM and FP participants. 54 participants used the recommended 
“double Dutch” method of contraception (condoms and another form), and 39 
participants used condoms alone. GUM participants were significantly more likely to 
use no form of contraception than FP participants (9 GUM vs, 2 FP, p = 0.030). 
Otherwise, there was no significant difference in the methods of contraception used 
by FP and GUM participants or by participants in each randomised sequence group. 
73 study participants were current smokers, and significantly more of these were 
GUM attendees (45 GUM vs. 28 FP, p = 0.013).
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Table 2.3.1 Characteristics of all, FP and GUM participants
All
Participants
n=200
FP
n=100
GUM
n=100
p Value
Age Median 25 25 25
Mean 28 27 28 *NS
Range 16-51 17- 43 16-51
Ethnicity White 185 92 93
Black African 5 2 3
Pakistani 4 3 1
Indian 2 0 2 *NS
Chinese 2 1 1
Other 2 2 0
Number o f None 5 3 2
sexual One 132 75 57
partners Two 48 17 31
(previous 12 Three 8 2 6 tp=0.005
months) Four - Six 6 3 3
More than ten 1 0 1
Previous STI 54 23 31 *NS
Contraception None 11 2 9 *p=0.030
Condoms 39 16 23 *NS
alone
Condoms and 54 29 25 *NS
another
method
COCP 95 50 45 *NS
Progesterone 21 14 7 *NS
methods
lUD 17 11 6 *NS
Sterilisation 14 4 10 *NS
Cap/Billings 3 3 0 *NS
Current 73 28 45 *p=0.013
Smoker
*X test. tW ilcoxon test, p value shows the significant difference between 
participants from each clinic. Sterilisation includes male and female.
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Table 2.3.2 Characteristics of all participants and randomised sequence groups
All
Participants
n=200
GUM first 
n=100
FP first 
n-100
p Value
Age Median 25 24 27
Mean 28 27 29 *NS
Range 16-51 17- 50 16-51
Ethnicity White 185 92 93
Black African 5 1 4
Pakistani 4 3 1
Indian 2 1 1 *NS
Chinese 2 1 1
Other 2 2 0
Number of None 5 2 3
sexual One 132 64 68
partners Two 48 27 21
(previous 12 Three 8 3 5 tN S
months) Four - Six 6 3 3
More than ten 1 1 0
Previous STI 54 27 27 *NS
Contraception None 11 6 5 *NS
Condoms 39 20 19 *NS
alone
Condoms and 54 24 30 *NS
another
method
COCP 95 45 50 *NS
Progesterone 21 13 8 *NS
methods
lUCD 17 8 9 *NS
Sterilisation 14 6 8 *NS
Cap/Billings 3 2 1 *NS
Current 73 41 32 *NS
Smoker
test. tW ilcoxon test, p value shows the significant difference between 
participants from each randomised sequence group. Sterilisation includes male and 
female.
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Diagnostic accuracy of strategies
Table 2.3.3 summarises the number o f correct and incorrect diagnoses made by each 
strategy on days 1 and 7. On day 1, the FP strategy produced 73 incorrect diagnoses 
and the GUM strategy produced 32 incorrect diagnoses. Statistical comparison using 
McNemar’s test showed that the FP strategy produced significantly more incorrect 
diagnoses than the GUM strategy (p<0.001, difference -20%; 95% Cl -27% to - 
14%). On day 7, the FP strategy produced 17 incorrect diagnoses and the GUM 
strategy produced 32 incorrect diagnoses. Statistical comparison showed that the 
GUM strategy produced significantly more incorrect diagnoses than the FP strategy 
(p=0.019, difference 7.5%; 95% Cl 1.3% to 13.7%). In order to determine if the 
sequence o f sampling influenced diagnostic accuracy, statistical comparison o f the 
randomised sequence groups was performed. No statistically significant difference 
in diagnostic accuracy was found on days I or 7 (p=l .000 and p=0.236 respectively).
Table 2.3.3 - Correct and incorrect diagnoses made by each strateg)
Diagnoses
(n=200)
Day 1 FP 
Strategy
(n=200)
Day 1 GUM  
Strategy
(n=200)
Day 7 FP 
Strategy
(n=200)
Day 7 GUM 
Strategy
(n=200)
True negative 
True positive 
False negative 
False positive
59 (29.5%)
68 (34%) 
32 (16%) 
41 (20.5%)
89 (44.5%) 
79 (39.5%) 
30 (15%)
2 (1%)
75 (37.5%)
108 (54%) 
17(8.5%)
0
75 (37.5%) 
93 (46.fM4)
31 (15.5%) 
1 (0.5%)
Correct
diagnoses
Incorrect
diagnoses
127 (63.5%) 
73 (36.5%)
168 (84%) 
32(16% )
183(9L5%0
17(8.5%)
168 (84%)
32(16% )
p Value* 
95% Cl
p<0.00l
-27%
(-20%) 
to -14%
p=O.OI9 (7.5%) 
1.3% to 13.7%
Cl = confidence interval. * M cNemar’s test.
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Specific diagnoses
Table 2.3.4 illustrates the specific diagnoses that were made in this study. 1 here 
were no significant differences in the numbers o f each infection diagnosed in 
participants from each clinic or in each randomised sequence group test). O f the
75 participants who had no microbiological abnormality detected, nine had a cervical 
ectopy, and one had an endocervical polyp.
Table 2.3.4 -  Specific diagnoses made in all participants, FP and GUM
Diagnoses All
Participants
(n=234)*
FPt
(n=113)
GUM t
(n=121)
GUM 
strategy 
first t
(n=119)
FP
strategy 
first t
(n=l 15)
No abnormality 75 39 36 34 41
detected
Bacterial 63 30 33 34 29
vaginosis
Candida 60 28 32 34 26
albicans
Chlamydia 16 7 9 7 9
trachomatis
Neisseria 1 0 1 0 1
gonorrhoea
Trichomonas 2 2 0 1 1
vaginalis
Streptococci 17 7 10 9 8
*27 participants had multiple diagnoses, hence total number o f infections = 234 
fStatistical comparison o f the diagnoses made in participants from each clinic and in 
each randomised sequence group using the test showed no significant difference 
(p> 0 .05).
Non-sexually transmitted infections
There were 140 diagnoses o f non- sexually transmitted infections. These consisted of 
63 cases o f Bacterial vaginosis, 60 o f Candida albicans, and 17 streptococcal
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infections. Of the 63 cases of Bacterial vaginosis the vaginal pH was greater than or 
equal to 5.0 in 61 cases. In the remaining two participants, the pH was 4.0. The 
vaginal discharge was described as ‘offensive’ in 27 of the 63 cases, profuse in 44 of 
the cases and thin and watery in 56 of the cases. The day 1 FP diagnosis (clinical) 
correctly identified 56 of these cases.
Of the 60 cases of Candida albicans, 33 had a normal vaginal pH (3.5 -  4.5). In the 
remaining 27 participants, the vaginal pH was elevated (> 4.5). The discharge was 
described as white in 44 participants, and ‘curd-like’ in 10. In 28 additional 
participants, the discharge was described as ‘thick’. Forty of these women 
complained of a vulval itch. The FP strategy (clinical) correctly diagnosed 30 of the 
cases on day I, and 58 of the 60 cases by day 7 (swab results).
The reference standard identified 17 cases of beta-haemolytic streptococcal 
infection. There were 12 cases of Lancefield Group B streptococci, 2 cases each of 
Lancefield group C and G streptococci, and 1 case of Lancefield group A 
streptococcus. At day 7 follow up these participants were offered treatment for 
streptococci if their symptoms persisted despite treatment for concurrent infections. 
Overall, eight participants were treated with antibiotics for streptococcal infections.
Sexually transmitted infections
Nineteen STI’s were diagnosed in 19 participants. There were 16 cases of Chlamydia 
trachomatis. Seven cases were diagnosed in participants attending the FP clinic and 
nine in participants attending GUM. There was no significant difference in the 
number of chlamydia cases diagnosed in each clinic (%^  test). The mean age of the
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participants with this infection was 23 years (range 18 -  40). Two of these women 
were married and the remaining 14 identified themselves as single. Three of these 
women had a history of a previous STI. One had a history of chlamydia infection 
only; one had a history of chlamydia infection and genital warts, and the third had a 
history of chlamydia, genital warts and Neisseria gonorrhoea. Of the 16 women 
diagnosed with chlamydia, 10 had a single sexual partner in the previous year, whilst 
6 had 2 partners in this time period. The FP and GUM strategies used the same 
specimen for chlamydia analysis therefore both correctly identified all cases of this 
infection.
Two cases of Trichomonas vaginalis were diagnosed in the study. One participant 
was a 35 year old married Chinese woman. Her contraceptive method was condoms 
alone. She gave no history of a previous STI, was a non-smoker, and had one sexual 
partner in the year prior to study recruitment. The other participant was a 24 year 
old Caucasian woman who lived with her partner. She used depoprovera and 
condoms for contraception. This participant smoked 20 cigarettes per day, and had 
one sexual partner in preceding year. She gave no history of a previous STI. Both 
cases of Trichomonas vaginalis were diagnosed correctly by GUM on day 1. The 
vaginal pH in both participants was greater than six. Both infections were 
misdiagnosed as Bacterial vaginosis on day 1 by the FP strategy (clinical diagnosis). 
The diagnoses were however made correctly on day 7 by the FP strategy.
One case of Neisseria gonorrhoea was diagnosed in the study. This participant was a 
29 year old Caucasian woman. She described herself as ' married/separated’, was a 
non-smoker, and used the lUCD alone for contraception. She had no history of an
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STI, and had three sexual partners in the year prior to the study. The vaginal pH in 
this participant was elevated at 5.2. This was explained at microscopy by the 
presence o f semen on the slide. I he diagnosis was missed on day 1 by the GUM 
strategy. The FP strategy incorrectly diagnosed Bacterial vaginosis on day 1. On day 
7, both the FP and GUM strategies correctly identified Neisseria gonorrhoea on the 
culture plates.
Multiple diagnoses
98 participants had a single diagnosis, 21 participants had two diagnoses, and 6 
participants had three or more infections diagnosed (Table 2.3.5). I he total number 
o f infections diagnosed was 234. Comparison of the number o f multiple diagnoses 
made in participants from FP and GUM, and from each randomised sequence group 
was made using the y} test, and no significant difference was found (p = 0.411 and p 
= 0.629 respectively).
Table 2.3.5 -  Multiple diagnoses
Number of 
diagnoses
All
participants
(n=200)
FP
(n=100)
GUM
(n=100)
GUM first 
(n=100)
FP first 
(n=100)
0 75 39 36 34 41
1 98 50 48 52 46
2 21 10 11 10 11
3-4 6 1 5 4 2
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Missed and incorrect diagnoses
The GUM strategy tailed to diagnose 21 cases o f Candida albicans, II of 
Streptococcus and I case o f Bacterial vaginosis. 13 o f these cases o f Candida 
albicans, 5 o f Streptococcus, and the case of Bacterial vaginosis were treated at day 
7 follow-up. O f the 75 participants with no microbiological abnormalities detected, 
the day I FP strategy incorrectly diagnosed 2 1 o f these participants with Candida 
albicans, 4 with Bacterial vaginosis and 1 with Trichomonas vaginalis. These 
participants were correctly identified as no abnormality detected by the FP strategy 
on day 7.
Sensitivity and specificity
fable 2.3.6 illustrates the overall sensitivity and specificity o f each strategy on days 
1 and 7.
Table 2.3.6 - Sensitivity and specificity of FP and GUM strategies
Strategy Sensitivity (%) Specificity (%)
Day 1 FP 68 59
Day 1 GUM 72 98
Day 7 FP 86 100
Day 7 GUM 75 99
FP = Family Planning, GUM = Genitourinary medicine
2.4 Discussion
Our study found that the strategy o f on-site microscopy (GUM) was superior to the 
strategy o f best clinical diagnosis (FP), in terms o f initial diagnostic accuracy, but 
that the FP strategy o f “triple swabs” was significantly more accurate than the GUM 
strategy in terms o f final diagnosis.
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This study demonstrated that in some patients, clinical findings can be difficult to 
interpret. Nearly all the cases of Bacterial vaginosis were correctly identified 
clinically (day 1 FP), however the majority of these participants had a typical watery 
discharge with a high vaginal pH. The cases of Candida albicans were not so 
typical. Almost half the partieipants with this infection had an elevated vaginal pFI 
(27/60), and one third denied vulval itch. This may have made the clinical diagnosis 
more difficult and is reflected by the day 1 FP strategy identifying only half the cases 
of Candida. Both cases of Trichomonas vaginalis were incorrectly diagnosed as 
Bacterial vaginosis by the day 1 FP strategy. This is perhaps because Trichomonas 
vaginalis is much less common than Bacterial vaginosis, and is also associated with 
an elevated vaginal pH and an offensive profuse discharge. Another factor, which 
may confuse the clinical findings, is the presence of more than one infection. This 
may cause a mixed pattern of symptoms and atypical signs. Although, the vaginal 
pH is a helpful diagnostic tool, it can also be altered by factors other than infections. 
Blood, semen and lubricating jelly can all elevate the vaginal pH (Somiex 1996a). 
An example of this was the case of Neisseria gonorrhoea, which was diagnosed in 
the study. The vaginal pH in this participant was 5.2 and there was a watery vaginal 
discharge. A clinical diagnosis of Bacterial vaginosis was made by the day 1 FP 
strategy. At microscopy, the presence of sperm was noted. This could account for the 
elevated vaginal pFI and the watery discharge. The participant had been questioned 
regarding timing of last sexual intercourse, however she had stated that this was 
more than one week prior to recruitment to the study. Microscopy findings are 
independent of these variables and this may explain why this was found to be more 
accurate than clinical diagnosis.
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The day 7 FP diagnoses were found to be more ace mate than day 7 GUM. The 
infections that the day 7 GUM strategy missed were all vaginal - Candida albicans , 
Streptococci and Bacterial vaginosis. This is because the vaginal specimen from the 
GUM strategy was only examined by microscopy in-house and not routinely plated 
onto culture media to yield growths of Candida albicans and Streptoeocci. Culture 
using Sabouraud’s medium is the most sensitive diagnostic method for Candida, with 
a sensitivity of 70% - 80% and a specificity of greater than 99% (Sobel 1997; Wilson 
2003). A Gram stain, which is utilised in GUM, will identify up to 65% of 
symptomatic cases (Sonnex & Lefort 1999). Although traditionally, an HVS has not 
been part of the GUM strategy, practice is changing and in order to save time and 
reduce workload for microscopists an HVS is being used in plaee of near-patient 
testing in some departments in the UK (Robinson & Rogstad 2003). Another 
criticism of the ‘triple swab’ strategy is that the transit time to the laboratory and the 
delay in inoculation of specimens might result in a reduction in diagnostic accuracy. 
In our study there was a delay of up to 12 hours between sampling and transportation 
of genital specimens, however this did not result in any significant loss of accuracy. 
This finding has been reiterated by other studies (Beverly et al. 1999; FitzGerald & 
Bedford 1996; Human & Jones 1986; Peterson, Danielsen, & Renneberg 1999; 
Schwebke, Venglarik, & Morgan 1999; WHO 1999).
Characteristics of participants and infections
No significant differences were identified when the randomised sequence groups 
were compared in terms of characteristics, infections diagnosed, and diagnostic 
accuracy. The sequence of sampling was not shown to influence the findings of the 
study. Comparison of participants from the GUM and FP clinics revealed many
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similarities such as age, ethnicity and previous STL There were however some 
notable differences. Significantly more GUM attendees used no contraception, and 
participants from this clinic had significantly more sexual partners in the previous 
year. This was not associated with an increase in the number of STTs diagnosed in 
GUM participants. Similarities in women attending FP and GUM clinics have been 
previously demonstrated (Gunneberg, Mann, & Radcliffe 1996; Radcliffe et al. 
1993). There were no significant differences in infections diagnosed in partieipants 
from each clinic (STI and non-STl). The diagnoses made in this study on the whole 
reflect the recognised order of frequency of occurrence and the typical reported 
prevalence of these infections (Hay 1999b). Many participants had no 
microbiological diagnosis found (n=75) and had complete symptom resolution with 
the reassurance offered by negative tests. Bacterial vaginosis was the most 
commonly diagnosed infection, closely followed by Candida albicans. Eight percent 
of participants were diagnosed with chlamydia and their mean age was less than 25 
years. A low prevalence of gonorrhoea in the study population is noted. The 
prevalenee found in our study is typical of that found in women in our region.
Strengths and weaknesses
The diagnostic accuracy of these strategies had not been previously compared. For 
this reason it was considered unethical to deny a GUM participant near-patient 
microscopy. We therefore employed a cross-over design in which all participants 
underwent both strategies thus minimising the chance of sub-optimal treatment. In 
order to eliminate sampling bias we randomised the sequence of strategies. The 
primary researeher performed all examinations thus avoiding observer variability. 
The researeher was blinded to the microscopy result until a clinical diagnosis was
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documented. All microscopy was performed by the duty MLSO who was blinded to 
the clinical diagnosis until a microscopy result was documented. All specimens were 
analysed in the same laboratory and were not labelled as study specimens to reduce 
bias further. In order to extrapolate our findings to routine clinical care we must 
assume that the researcher’s clinical acumen was representative of FP staff. To 
confirm this, the knowledge of a sample of FP staff was assessed, and found to be 
comparable with the researcher’s laiowledge (Melville, Bigrigg, & Nandwani 2003). 
To evaluate accuracy, the outcome of a test or strategy is compared with an 
independent reference standard. “Gold standards” providing full certainty are rare 
and sometimes no suitable independent standard is available (Knottnerus, van Weel, 
& Muris 2002). No independent reference standard existed therefore we utilised a 
combination of both strategies.
Our research was designed to compare strategy accuracy in terms of diagnosis. No 
comment can therefore be made regarding the clinical implications of the diagnosed 
infections. This is of particular relevance for the streptococcal and Candida 
diagnoses. Group B Streptococcus is known to colonise the genital tract in up to 18% 
of healthy women (Rowen 1993). Mean vaginal isolation rates for Candida albicans 
from asymptomatic women have been reported as 8% (Sonnex & Lefortl999). All 
participants in our study were symptomatic at recruitment, and were only offered 
treatment for these infections on day 7 if still symptomatic. Although isolation of 
streptococci from the genital tract is often thought to be incidental (Shaw, Mason, & 
Scoular 2003), the vaginal micro-flora is a complicated environment and our 
understanding of conditions such as desquamative inflammatory vaginitis is limited 
(Donders et al. 2002). Further research could be performed in this area, with
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participants being randomised to treatment or no treatment of these infections with 
post-treatment follow-up.
Implications for clinical practice
This study has shown that in terms of immediate diagnosis, microscopy is more 
accurate than clinical judgement. Managing patients solely on the basis of clinical 
diagnosis may result in over, or incorrect treatment. This will have cost implications 
and consequences for antibiotic resistance. The FP strategy did not miss any STIs. 
This is reassuring for clinicians who do not have access to near-patient testing. This 
strategy does however incur a delay of approximately seven days in obtaining 
results. This may be acceptable in areas of low female gonorrhoea prevalence, and is 
similar to the duration taken to obtain a chlamydia result. A delay of seven days in 
the diagnosis of Bacterial vaginosis and Candida albicans should not cause any 
serious morbidity. The exception would be Bacterial vaginosis in pregnant women.
In eommon with much of UK GUM practice, the vaginal specimen from the GUM 
strategy was examined by microseopy in-house but not routinely plated onto culture 
media. To increase accuracy of this strategy, a vaginal specimen could be sent to the 
laboratory for culture. We have found that FP and GUM attendees have many similar 
characteristics, and show no significant difference in the infections diagnosed. We 
therefore feel it is possible to develop a unified protocol for the management of 
women presenting with vaginal discharge. The findings of this study have already 
been used to alter our clinical strategies. A vaginal specimen is now taken from all 
symptomatic GUM attendees at our centre, and we are assessing ways to select those 
patients who would benefit from the addition of near-patient testing. We have
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identified an area of the FP strategy where costs can be streamlined. Both the HVS 
and endocervical swabs were being tested for vaginal and endocervical pathogens. 
This duplication is unnecessary, and the monies saved from discontinuing this 
practice have been used to fund the HVS in GUM participants. A move away from 
near-patient microscopy is likely in the future with wider availability of non-invasive 
sampling techniques.
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CHAPTER 3: CLIENT PERSPECTIVES ON SEXUAL HEALTH SERVICE 
PROVISION.
3.1 Introduction
In order to provide more holistic sexual health care, reorganisation and convergenee 
of FP and GUM services in the UK is taking place. UK government policy has 
stressed the need for health services to be more responsive to the expressed needs 
and views of the public and service users (Department of Health 1989; Department 
of Health 1995). A recommendation made by the English National Strategy for 
Sexual Health and HIV is that service users should “play a big part in reshaping 
services” (Department of Health 2001). Reorganisation of sendees in some regions 
has led to the development of one-stop sexual health clinics (Dawson et al. 2000; 
Jones 2000; Stedman & Elstein 1995; Wilkinson, Hampton, & Bradbeer 2000). The 
Sandy ford Initiative in Glasgow provides both GUM and FP services under the one 
roof. Integration and modernisation of services has necessitated changes in practice. 
Attention is being given to the development of unified clinical systems and common 
protocols. A particular area of interest is the role of near-patient testing, which is 
typically utilised in GUM, but not in FP clinics (Robinson & Rogstad 2003). One of 
the key principles of the Sandy lord Initiative is to consult with service users to 
ensure equity and access in the development and delivery of services (Laughlin et al. 
2001). A study was performed at the Sandy lord Initiative to assess diagnostic 
accuracy of the current FP and GUM strategies for the management of women with 
vaginal discharge (Chapter 2), (Melville, Nandwani, & Bigrigg 2003). Thus the 
opportunity arose to carry out a questionnaire-based qualitative study to evaluate 
user views of our FP and GUM departments, attitudes towards near-patient testing
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and general comments on our service prior to implementation of change. Although 
user views have been sought in independent FP and GUM settings (Evans & 
Farquhar 1996; Harris, Peckham, & Walsh 1997; Munday 1990; Rogstad 1991), no 
qualitative studies have been performed to draw a eomparison between these two 
clinics.
3.2 Methods
200 consecutive women presenting with the main complaint of vaginal discharge 
were recruited to a study to compare the FP and GUM strategies for the management 
of vaginal discharge (Chapter 2). 100 women were recruited from each clinic 
between December 2001 and June 2002. Once recruited, all women were invited to 
participate in a researcher administered structured questionnaire which was 
completed during the eonsultation process (Appendix III). A brief telephone 
interview was completed one week after the initial consultation. The questionnaire 
eovered: access to and choice of serviee, attitudes towards near-patient testing, views 
on time spent in the clinic, and open questioning regarding overall views of the 
service and suggestions for change.
Statistical comparison of the characteristics of participants from the two clinics was 
made using the test and the Wilcoxon test. This study received approval from the 
Greater Glasgow Primary Care Trust Research Ethics Committee.
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3.3 Results
All 200 women completed the study and follow-up. Table 3.3.1 shows the 
characteristics of the study participants. The mean age of participant was 28 years, 
and there were no significant differences in the mean age of participants from each 
clinic. The partieipants included 5 black-African women, 4 Pakistani women, 2 
Indian women and 2 Chinese women.
No statistically significant differences in age, ethnicity and previous sexually 
transmitted infections between the populations of GUM and FP participants were 
demonstrated. GUM participants were significantly more likely to use no form of 
contraception and had significantly more sexual partners in the last year than FP 
clinic participants. There was no significant difference in the number of previous 
STTs in the two groups of participants.
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Table 3.3.1 -  Characteristics of study participants
and another 
method
Ail
Participants
n=200
FP
n=100
GUM
n=100
p Value
Age Median 25 25 25
Mean 28 27 28
Range 16-51 17- 43 16-51
Ethnicity White 185 92 93 *NS
Other 15 8 7
Number of None 5 3 2
sexual partners One 132 75 57
(previous 12 Two 48 17 31
months) fhree 8 2 6 tP -0 .005
Four - Six 6 3 3
More than 1 0 1
ten
Previous STI 54 23 31 *NS
Contraception None 11 2 9 *P=0.()3()Condoms 39 16 23 *NSalone
Condoms 54 29 25 *NS
*X test 
Wilcoxon test.
Access to, and choice of service
Participants were asked how far they felt it was reasonable to travel to access a 
service such as the Sandyford Initiative. These results are summarised in Chart 3.3.1. 
70 participants would only travel up to 5 miles; 78 participants would travel between
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6 - 1 0  miles; 38 participants would travel 11 - 2 0  miles, and 14 participants would be 
prepared to travel more than 20 miles to access such a service.
Chart 3.3.1
Distance clients would be prepared to travel to 
access this service
7%
19% 35%
39%
□  1-5 miles 
■  6-10 miles
□  11-20 miles
□  >20 miles
1
1 he participants were questioned regarding the service provider that they would 
prefer to access for a similar problem if the choice was available. The categories 
offered were: a GP, a hospital clinic, a local FP clinic, a local GUM clinic, a central 
FP clinic, or a central GUM clinic (such as the Sandyford Initiative). Table 3.3.2 
summarises these results. 86 participants (43%) chose the central FP clinic option; 
66 participants (33%) chose the central GUM clinic option; 23 participants (11.5%) 
chose the local GUM clinic option; 13 participants (6.5%) chose the local FP clinic 
option; 12 participants (6%) chose the GP option, and no participant expressed a 
preference to attend a hospital-based clinic.
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Table 3.3.2 — Clients’ preference of serviee provider
Service provider Preference (%)
(n=200)
GP 12(6%)
Hospital clinic 0
Local FP clinic 13 (6.5%)
Local GUM clinic 23(11.5%d
Central FP clinic 86 (43%)
Central GUM clinic 66 (33%)
I he responses to this question were split and analysed according to the clinic the 
client attended on the day o f study participation (central FP or central GUM). The 
majority o f participants expressed a preference for that same service provider, with 
81 o f the 100 FP participants expressing a preference for the central FP clinic option, 
and 63 o f the 100 GUM participants expressing a preference for the central GUM 
clinic option (Charts 3.3.2, 3.3.3).
Chart 3.3.2
Family Planning clients future choice of service
4% 11% ___1%
□  Central FP
□  Central GUM
□  GP
■  Local FP
■  Local GUM
81%
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Chart 3.3.3
Genitourinary Medicine clients future choice of service
□  Central FP
□  Central GUM
□  GP
■  Local FP
■  Local GUM
63%
Views on near patient testing
All participants had undergone both current strategies o f near-patient testing (at the 
time o f the study only available in GUM), and provisional clinical diagnosis offered 
by FP (with confirmed results in 7 days). We sought their views regarding the 
different approaches. Although most participants said that near-patient testing 
resulted in a longer time spent in clinic, 99% (n=198) said they would prefer to wait 
tor these immediate results and receive initial treatment based on microscopy whilst 
awaiting confirmatory culture results. Comments included: “ 1 liked receiving 
immediate results even if they were negative” and “1 was previously treated in the 
FP clinic tor my symptoms. Although they thought 1 had thrush, it turned out this 
was wrong and I think it is much better to wait for accurate results". Only two 
participants said that they would prefer to wait seven days for their results and 
treatment. 1 hese two participants felt that the wait for a microscopy-based diagnosis 
would be too long.
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Time spent in clinic
This was calculated from the time of arrival, and included any time waiting to be 
seen, and waiting for microscopy results. Although the participants presented to 
different clinics, all underwent an identical consultation process. The time spent in 
clinic ranged from 40 minutes to 4 hours, with a mean time of 99 minutes. The mean 
time spent by those participants who presented to the GUM service was 113 minutes 
(range 40 - 180 minutes), versus a mean time of 85 minutes (range 45 - 240 minutes) 
at the FP service. Nine participants spent greater than 160 minutes in clinic. A single 
participant spent 4 hours in clinic (FP), however in addition to investigation of 
vaginal discharge she underwent counselling for, and insertion of a contraceptive 
implant. 78% (n=156) of participants felt that the time they spent in clinic was 
“about right”, and 22% (n=44) felt that this was too long. No participant felt that the 
time spent in clinic was too short. The mean time spent in clinic by those participants 
who felt it had been “too long” was 122 minutes (range 60 -  180 minutes) compared 
with a mean time of 88 minutes spent by those who felt it was “about right” (range 
40 -  240 minutes).
Future use of the service
Participants were asked if they were likely to reuse this service in the future should 
the need arise. 181 participants (94 FP, 87 GUM) stated that they would be “very 
likely” to use this service again in the future. 18 participants would be “quite likely” 
to reuse the service. Only 1 participant stated she would be “unlikely” to re-attend 
this service (GUM) because she was moving away from Glasgow.
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(îeneral views and suggestions for improvement
Overall the participants’ views o f the service were very encouraging (Box 3.3.1 ). 57 
participants’ felt that the consultation was “ fine” and 40 felt that is was “good". 
Others commented that it was a “non-judgemental and friendly environment” and the 
staff “put me at ease”. Many felt “relieved to know what was wrong”.
Box 3.3.1 - Positive feedback from users
‘Excellent service’
‘Completely satisfied’
‘They were very informative and non-judgemental’ 
‘I appreciated all the help and advice’
‘Reassuring -  very comfortable and relaxed’
When asked if they had any suggestions regarding how the service could be 
improved, we received useful feedback (Box 3.3.2). 10% of those questioned felt 
that we needed more staff as the waiting time was too long in both clinics and it was 
difficult to get appointments. Many participants offered practical suggestions about 
the clinics’ amenities and environment. Better parking facilities were requested and 
clearer signage inside the building to direct patients to the relevant clinic. One user 
stated. ”1 came in the wrong door and it was quite a shock to see all these men". 
Some participants had concerns regarding the ‘check-in procedure'. The general 
feeling was that the area was not discrete enough and there were concerns that 
private information might be overheard. This concern has been expressed in previous 
qualitative reports o f GUM user views (Evans & Farquhar 1996).
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Box 3.3.2 -  Some suggestions for change and improvement
‘ I'he drop-in (clinic) was too busy. More staff would be 
helpful’
‘Need better links between family planning and 
genitourinary medicine’
‘Waiting area was not discrete enough’
‘Need better parking facilities’
‘Music and a coffee machine in reception would be 
good’
3.4 Discussion
Clients attending FP and GUM clinics are often thought to have quite different 
characteristics. This study found that the two populations shared many similarities. 
I here were however some significant differences such as use o f contraception and 
number o f sexual partners, which may be important. GUM attendees were more 
likely to use no form o f contraception than FP users. This may rellect a lack of 
contraceptive services in the GUM setting. This must be taken into consideration 
when developing our clinics.
I he majority o f participants would choose to re-attend either a central FP or GUM 
clinic. This response was unsurprising as we were asking women who had already 
chosen to attend our service and therefore this question was subject to bias. We were 
interested to learn that very few women in this study would opt to see their GP for a 
similar problem and that none would attend a hospital based clinic if given a choice. 
Expansion o f sexual health services into primary care has been recommended 
(Department o f Health 2001), however other authors have similarly reported that 
patients may prefer to attend GUM or FP clinics (Cassel & Brook 2002; Dawson &
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Greenhouse 1996; Stedman & Elstein 1995). We should be aware of this when 
developing sexual health services at a local level.
The time spent in clinic included the time to undergo the study, however this added 
only 15 minutes to the total time. The majority of time was spent waiting to be seen 
initially (most women were recruited from ‘drop-in’ clinics), and waiting whilst near 
patient microscopy was performed. The participants of this study considered a total 
time of 90 minutes spent in clinic as acceptable. 120 minutes spent in clinic was 
however considered too long. The longer time spent in the GUM clinic appears to 
reflect an increased waiting time. This is mirroring the increase in the number of 
STTs and resulting attendances at GUM clinics, which has occurred over the past 10 
years in the UK (Adler 2003). Since this study was completed we have reviewed our 
check-in procedure and are streamlining the service by a variety of means including 
nurse triaging.
Reducing routine microscopy minimises the workload for staff and decreases waiting 
times for clients. This study demonstrates overwhelmingly that if given a choice, 
clients prefer to receive immediate results from near-patient microscopy, even if this 
increases their time spent in clinic. This has major implications for resources in 
departments offering sexual health care. Some clinics have introduced a policy of no 
microscopy for patients fulfilling certain conditions. This saves time for patients in 
clinics and reduces workload for mieroscopists (Andrews et al. 1994). In the longer 
term the introduction of non-in vas ive diagnostic teclmiques, which utilise nucleic 
acid technology may offer a solution. Our ‘one-stop’ sexual health service was
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established three years ago and it is essential that we continue to seek feedback from 
our users as we strive to integrate and modernise our services.
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CHAPTER 4; IMPACT OF THE SEXUALLY TRANSMITTED INFECTIONS 
FOUNDATION COURSE ON THE KNOWLEDGE OF FAMILY PLANNING 
NURSES AND DOCTORS
4.1 Introduction
Staff involved in the provision of sexual heath care will require training and 
educational support in order to facilitate implementation of the English National HIV 
and Sexual Health Strategy. Modernisation of sexual health services has meant 
altered and expanded roles for health care workers. Many disciplines are now 
involved in the provision of sexual health care including family planning nurses and 
doctors, youth clinic staff, GP’s and practice nurses (Department of Health 2001). It 
is vital that staff are equipped with the knowledge and skills to confidently and 
competently extend their roles (Miles 2002).
The Diploma of the Faculty of Family Planning and Reproductive Healthcare 
(DFFP) is widely recognised as the optimal training route for gaining knowledge and 
skills in contraception and reproductive health. It is generally attended by GP’s, 
trainees in Obstetrics and Gynaecology, FP nurses and doctors, and trainees in 
GUM. In 2000, the General Training Committee of the FFPRHC recommended that 
the DFFP syllabus be re-written, with a particular emphasis on enhancing the STl 
module to provide course participants with skills appropriate for sexual health 
consultations to Level one of the National Strategy for Sexual Health and HIV.
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The Sexually Transmitted Infections Foundation (STIF) course was developed by 
the Medical Society for the Study of Venereal Diseases (MSSVD) as a UK-wide 
initiative to support the implementation of the English National HIV and Sexual 
Flealth Strategy. In March 2002, the first Scottish STIF course was run in Glasgow. 
The duration of the course was two days, and the programme consisted of a 
combination of short lectures and workshops. The aim of this course was to provide 
the participants with the basic knowledge, expertise and attitudes for the effective 
management of STTs. GUM and FP staff and GP’s attended the course.
As the STIF course had recently been introduced, no previous studies had assessed 
the educational value of the course. This study was therefore undertaken to 
determine the impact of the STIF course on the Imowledge of FP doctors and nurses. 
For the purposes of the study we chose to assess the knowledge of cervical and 
vaginal infections, which is taught as a workshop in the STIF course.
4.2 Materials and methods
This prospective study was performed in the department of FP at the Sandy ford 
Initiative in Glasgow. Non-sessional core FP staff who had applied for a place on 
the STIF course were invited to undergo knowledge assessment prior to and 
following attendance at the course. A variety of different grades of doctors 
participated in the study, including clinical medical officers, FP trainees and 
consultants. The nmses were all full-time members of staff. No member of staff 
declined to take part in this study.
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Design
16 family planning doctors and 4 family planning nurses were assessed prior to the 
STIF course. The researcher administered four clinical case scenarios. The cases 
were: Candida albicans. Trichomonas vaginalis. Bacterial vaginosis, and Chlamydia 
Irachomalis (Box 4.2.1). Each ease consisted of a patient history which included 
symptoms typically associated with the infection concerned (Appendix IV). The 
history was accompanied by a clinical photograph o f the condition concerned. 1 he 
photographs showed the typical signs associated with each infection.
Box 4.2.1 -  Case topics
Candida albicans 
Trichomonas vaginalis 
Bacterial vaginosis 
Chlamydia trachomatis
The participants were asked to answer three questions relating to each case (Box 
4.2.2). The vaginal pH was provided for question two. A point was awarded for 
each o f these three stems, allowing a maximum of 12 points. The participants were 
asked to give a primary (not differential) diagnosis. Within 3 months o f the STIF 
course, each doctor and nurse were re-tested with the initial scenarios. Answers and 
feedback were provided on completion.
Box 4.2.2 -  Questions asked of participants
1) What is your provisional diagnosis based on the history and 
photograph?
2) The vaginal pH is now provided - does this alter your diagnosis (and 
to what)?
3) How would you manage this patient?
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Statistical analysis
Two sample t-tests and confidence intervals for the difference of two means were 
employed to compare all participants and the doctors and nurses scores before and 
after attendance at the course. One sample t-tests and confidence intervals for the 
difference of two means were employed to compare the doctors and nurses scores. 
As the numbers in the study were small we did not perform sub analysis of the 
results for different grades of doctors.
4.3 Results
Two of the 20 initial participants in this study (one doctor and one nurse) were not 
re-assessed, as they did not attend the course. They were therefore excluded from the 
analysis. 18 members of staff were re-tested. Table 4.3.1 shows the mean (and 
standard deviation), median pre- and post-course scores, and mean difference in 
scores.
All participants
There was a mean increase of 2.5 points in all participants’ scores. Comparison of 
the pre- and post-course mean scores revealed a statistically significant improvement
( p - 0.001).
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Table 4.3.1: The mean (and standard deviation), median pre- and post-eonrse 
scores, and mean difference in scores
Pre­
course
score
Post­
course
score
*Mean
difference
(95%CI)
p value
All Mean
participants (SD) 
(n=18)
Median
8.2 (2.3) 10.7(1.8)
Doctors
(n=15)
Nurses
(n=3)
Mean
(SD)
Median
Mean
(SD)
Median
9.0
8.6 (1.9)
9.0
12.0
0.6  ( 1.8 )
12.0
6.0 (3.0) 11.0(1.7)
+2.5 
(1.1 -3 .9 )
+ 2.0 
(0 .7 -3 .3 )
+5.0
(-3 .6 -1 3 .6 )
0.001
0.006
0.130
6.0 2.0
*t-test
Nurses
The nurses' knowledge showed improvement following attendanee at the STIF 
eourse, with two o f them gaining full marks and none o f them gaining less than their 
initial scores. Their mean increase in score was 5.0 points. Comparison o f their pre- 
and post- eourse scores however, failed to show a statistically significant increase in 
mean score (p = 0.130). This is likely to be due to the small number o f participants.
Doctors
Two of the doctors gained full points at both assessments. Nine o f the doctors' 
scores improved after the STIF course, however the score o f two doctors’ who had
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high baseline result decreased (from 9 to 7 and from 9 to 8). The mean increase in 
all doctors’ scores of 2.0 points was statistically significant (p = 0.006).
Comparison of doctors and nurses
A comparison of the mean increase in scores of the doctors and nurses failed to reach 
statistical significance (-3.0; -6.4 -  0.4; p = 0.08). The data suggests that the nurses 
may have benefited more, however as the numbers were small this was inconclusive.
Knowledge of individual infections
All participants correctly diagnosed and managed the Candida vulvovaginitis case 
scenario pre- and post-STIF course. The Bacterial vaginosis question was the most 
frequently incorrect (16 participants pre-course answered this incorrectly), with all 
wrong participants confusing this with Candida infection. Provision of the typical 
vaginal pH associated with Bacterial vaginosis (pH >5.0) did not change the 
participants’ answers. Post-course the Bacterial vaginosis question was still 
incorrectly diagnosed as Candida vulvovaginitis by six of the participants.
4.4 Discussion
In recent years, FP and GUM services have become more integrated (Dawson et al. 
2000; Jones 2000; Kane & Wellings 1999; Stedman & Elstein 1995; Wilkinson. 
Hampton, & Bradbeer 2000). This move towards integrated sexual health service 
provision is in line with the recommendations of the English National Strategy for 
Sexual Health and HIV (Department of Health 2001). With the introduction o f ‘one- 
stop sexual health clinics’ such as the Sandyford Initiative in Glasgow, FP doctors
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and nurses will be required to assess and manage clients with vaginal discharge and 
STTs more frequently. Courses such as the STIF course run by the MSSVD play a 
vital role in providing staff with the education and training they need to competently 
extend their roles. In addition, a revised DFFP syllabus has now been introduced. 
Attendance at the STIF course will exempt a candidate from the theoretical part of 
the DFFP Sexually Transmitted Infections module.
The main weakness of our study was the small size. In addition, there are limitations 
of assessing knowledge by this somewhat artificial method. Examination of a patient 
will reveal more details than a photograph and in clinical practice a differential 
diagnosis would often be made. To compensate for this, we endeavoured to use 
pictures and case histories, which were as representative and realistic as possible. 
The same scenarios were used before and after the course. All core members of staff 
were invited to attend the STIF course, and to participate in the study, thus 
minimising selection bias.
It was interesting to confirm our suspicions that Candida vulvovaginitis is frequently 
over diagnosed, perhaps at the expense of diagnosing other conditions such as 
Bacterial vaginosis. Vaginal pFI measurement is not universally employed in the 
family planning setting. This was reflected by the participants’ uncertainty regarding 
the normal vaginal pFI as well as that found in association with infections. This area 
of knowledge did however show improvement following attendance at the STIF 
course.
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Our study suggests that knowledge increased following attendance at the STIF 
course. The STIF course is an important educational tool for staff working in the 
field of sexual and reproductive healthcare. A larger study of this type assessing a 
wider range of subject matter would enable further evaluation of the STIF courses’ 
impact on Imowledge.
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CHAPTER 5: DISCUSSION
Over the past decade in the UK, GUM and FP services have become more 
integrated. Commissioners and eare providers realised that whilst functioning 
separately, these services failed to provide client centered care. Service duplication 
also meant that resources were not being optimised. Closer links between providers 
of sexual health care have been encouraged by the government in the English 
National Sexual Health and HIV Strategy, and have been supported by professionals 
working in both fields (Department of Health 2001; Wilkinson, Hampton, & 
Bradbeer 2000).
In June 2000, central FP and GUM services in Glasgow became housed together as 
the Sandyford initiative. This change in practice created an opportunity to evaluate 
the services we provided. Our strategies for patient care were assessed and attention 
given to implementing new protocols which could be used throughout the Sandyford 
Initiative. It was vital that our evolving service was responsive to the needs and 
views of users. Consultation with our clients was therefore undertaken. We 
recognised the importance of ensuring our staff were equipped with the knowledge 
and skills to confidently extend and alter their roles in this newly integrated 
environment. Accordingly staff were provided with the opportunity to attend 
educational initiatives such as the STIF course. The studies presented in this thesis 
were performed in order to evaluate the proposed changes prior to implementation.
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Traditionally departments of GUM have utilized near-patient microscopy for 
examination of genital specimens from their patients (Andrews et al. 1994). The 
benefit of this strategy is that it confers immediate results for patients. This can 
eliminate a delay in treatment and may offer prompt reassurance to the anxious 
patient. Microscopy is the recommended method of diagnosis for Bacterial 
vaginosis, however culture is a more sensitive diagnostic method for Candida 
albicans. Trichomonas vaginalis and Neisseria gonorrhoeae (Bickley et al. 1989; 
Daniels & Forster 1999; FitzGerald & Bedford 1996). It must therefore be noted that 
the immediate results offered by the GUM strategy are preliminary only, and the 
confirmatory Neisseria gonorrhoeae result will take at least 48 hours. Chlamydia 
trachomatis is diagnosed by a NAAT and this result will not usually be available 
within seven days.
Huge demands have been placed on sexual health services in the UK over the past 
decade. All STTs have increased in England over the past six years and this has 
resulted in a doubling in attendances at GUM departments (Adler 2003). Services 
have been unable to cope with this increased demand. Neither adequate resources 
nor manpower have been available. The Department of Flealth’s Monk Report set a 
target that all patients should be seen at a GUM service within 48 hours (Monks et 
al. 1998). The length of waiting time to be seen at a GUM clinic within the UK has 
increased by eight days for women and seven days for men from 2001 to 2002 
(Flouse of Commons Health Select Committee 2003). This has major public health 
implications, as STTs are communicable diseases. Methods of tackling these 
problems are being addressed and sexual health providers are assessing innovative
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methods in which to streamline their services. Primary care teams who will provide 
‘level one care’ may meet some of the increased demand (Department of Health
2001). Other modifications to practice include the introduction of patient triage and 
an expanded role for nurses (Miles 2002). In order to shorten clinic visits, some 
GUM departments are selecting patients who do not require near-patient microscopy 
(Andrews et ai. 1994).
Although the conventional function of the FP clinic was contraception, this remit has 
changed, and amongst other services, sexual health care and management of STFs 
are now provided in most departments. FP services remain on the whole based in the 
community and do not typically have access to on-site microscopy services. Instead, 
local laboratories are utilized. Patients seeking sexual health care advice may chose 
to attend their GP or an FP clinic rather than a GUM service, to avoid the perceived 
stigma associated with GUM (Scoular, Duncan, & Hart 2001).
Integrating our FP and GUM services at the Sandyford Initiative has offered many 
challenges. The departments initially functioned in parallel and therefore methods 
were assessed in which to deliver a rmified service. Each department had separate 
protocols and strategies for patient care. These had evolved mainly by custom and 
practice rather than from an evidence base. This was an area where change was 
considered achievable and beneficial. Both departments had a strategy for the 
management of vaginal discharge. Neither of these were evidence based and we 
could find no previous studies comparing these strategies in terms of diagnostic 
accuracy (Miles et al. 2002). The study presented in Chapter 2 was therefore
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performed. The conclusion that the GUM strategy offered greater initial diagnostic 
accuracy and the FP strategy offered greater final diagnostic accuracy was reached. 
On the basis of the findings of this study our practice at the Sandyford Initiative has 
been modified. An FI VS is taken from all symptomatic women and microscopy is 
not performed on asymptomatic women. This study also showed that there were no 
significant differences in the infections diagnosed in GUM and FP attendees. This 
would suggest that these populations have similar needs as far as sexual health care 
is concerned.
Consultation with patients regarding service provision is now encouraged throughout 
the NFIS (Department of Health 1989; Department of Health 1995). As part of the 
process of change at the Sandyford Initiative, we thought it vital that we determined 
the views of our users. The majority of participants in the study presented in Chapter 
3 said they would travel up to 10 miles to access a sexual health service. Most stated 
a preference to attend a GUM or FP clinic rather than attend their GP. This may be 
due to the anonymity and confidentiality afforded by these services (Cassel & Brook
2002). This has implications for implementation of the National Sexual Health and 
HIV Strategy, as primary care teams will be playing a more active role in the 
management and preventions of STFs. Participants in our study overwhelmingly 
voiced a preference for receiving near-patient microscopy as offered in GUM. These 
patients were all symptomatic (of vaginal discharge) at presentation. Asymptomatic 
patients may not uphold this view. Nevertheless these views should be considered 
when modifying our services, and a balance between patient choice, and cost-benefit 
should be reached.
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Finally, in Chapter 4, we evaluated the educational impact of the STIF course. FP 
nurses and doctors attended this course, and we evaluated their knowledge prior to 
and after attendance. Although only a small section of the STIF course syllabus was 
assessed (cervical and vaginal infections), staff knowledge did show significant 
improvement. It is important that educational interventions are part of an ongoing 
evaluation cycle (Wilkes & Bligh 1999), and that staff are regularly updated on 
developments in their field of work.
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CHAPTER 6: CONCLUSIONS
• The FP and GUM strategies for the management of vaginal discharge both have 
advantages.
• The GUM strategy is more accurate in terms of initial diagnosis.
• The FP strategy is more accurate in terms of final diagnosis.
• The addition of an HVS for culture to the GUM strategy would result in 
increased accuracy of the final diagnosis.
• Diagnosis based solely on clinical symptoms and signs results in over- and mis­
diagnosis of infections and over-treatment of patients.
• GUM and FP users share many characteristics.
• Symptomatic GUM and FP users prefer to receive immediate results from near­
patient microscopy even though this requires a longer time spent in clinic.
• The STIF course is of educational value to FP nurses and doctors.
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Future research
é A  further study assessing the pathogenicity of streptococci and their relationship 
with vaginal discharge could be performed. Women presenting with vaginal 
discharge could be randomized to treatment or no-treatment of these conditions, 
with prolonged follow-up.
o Further evaluation of users choice of sexual health service could be undertaken. 
It would be interesting to determine the rationale for choosing to attend FP, GUM 
or primary care. This will be important for commissioning future services.
• Additional areas of the STIF course syllabus could be evaluated and the 
educational needs of staff assessed by means of further knowledge appraisal.
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APPENDIX I 
Gram-staining method
After fixing the specimen on a glass slide by heating, four reagents are then applied 
in the following order:
1. A basic pararosaniline violet dye, such as crystal violet
2. An aqueous solution of iodine
3. A decolourising agent, such as acetone
4. A red counterstain, such as diluted carbol fuschin
The two dyes and the iodine should be kept on the slide for at least 15 seconds. The 
time during which the specimen is exposed to the decolourising agent is critical. This 
depends on the thiclmess of the specimen, and the agent used. Acetone decolourises 
within 3 seconds.
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APPENDIX II -  Photomicrographs
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APPENDIX III
Patient Questionnaire (to be administered by the researcher)
1) How far do you think it is reasonable to travel to a clinic, which offers this 
service? _____________________________ (miles)
2) In which setting would you prefer to have youi* swab tests taken?
At your family doctor/GP □
At your local family planning clinic □
At your local GUM/sexual health clinicD 
At a central family planning clinic □
At a central GUM/sexual health clinic □ 
At hospital □
Other (please specify)
3) Which of the following do you most agree with?
I would prefer to wait today to get some of my results □
I would you prefer to wait 7 days for my final results □
4) Which of the following do you most agree with?
I would prefer treatment today before all my results are available □ 
I would prefer treatment once I have all my results □
At end of Day 1 clinic visit
5) Approximately how long have you spent in the clinic today?
6) How do you feel about the length of time you have spent in the clinic 
today?
Too long □ 
About right □ 
Too short □
7) How likely is it that would you come to this clinic again?
Very likely □ 
Quite likely □ 
Unlikely □
Very unlikely □
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8) Overall, how do you feel about your visit to the clinic today?
9) Do you have any suggestions on how your visit could have been 
improved?
Questions for day 7 telephone follow-up
10) Has the reason you attended the clinic fully resolved? Yes/No
11) How satisfied overall have you been with the service you have had?
Very satisfied □ 
Quite satisfied □ 
Not satisfied □ 
Very unsatisfied □
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APPENDIX IV
Case Scenarios 
Case 1- Bacterial Vaginosis
This 25 year old woman presented to the FPC complaining of vaginal discharge. She 
described the discharge as heavy, offensive, and white. She denied vulval itch but 
complained of some irritation.
1) What is your provisional diagnosis based on the history and photo?
2) The vaginal pH is 5.5 -  does tliis alter your diagnosis (and to what)?
3) How would you manage this patient?
Case 2 - Trichomoniasis
This 29 year old woman presented to the FPC complaining of an offensive vaginal 
discharge associated with vulval soreness and itching. She described the discharge as 
yellow.
1 ) What is youi' provisional diagnosis based on the histoiy and photo?
2) The vaginal pH is 6.3 — does this alter your diagnosis (and to what)?
3) How would you manage this patient?
Case 3 -  Candidiasis
This 21 year old woman presented to the FPC complaining o f a white vaginal 
discharge associated with superficial dyspaieunia and vulval swelling.
1) What is youi- provisional diagnosis based on the history and photo?
2) The vaginal pH is 4.0 -  does this alter yoin diagnosis (and to what)?
3) How would you manage this patient?
Case 4 - Gonorrhoea
This 35 year old woman presented to the FPC complaining of dysuria and slight 
increase in vaginal discharge. She had also noticed that her discharge was blood 
stained on occasion. Her symptoms had been present for 2 weeks. She denied vulval 
itch.
1) What is youi- provisional diagnosis based on the histoi-y and photo?
2) The vaginal pH is 4.5 -  does this alter your diagnosis (and to what)?
3) How would you manage this patient?
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Impact of the Sexually
Transmitted Infections
Foundation course on the
know ledge of family planning
nurses and  doctors
There has been convergence of genitourinary 
m edicine and reproductive healthcare serv­
ices in the United Kingdom to produce "one 
stop sexual health  clinics" such as the Sandy- 
I'ord Initiative in  Glasgow,' ’ As part of service 
developm ent a num ber of educational in itia­
tives such as the  Sexually Transm itted Infec­
tion Foundation (STIP) course have been in i­
tiated to ensure th a t m inim um  skills and 
competencies arc obtained. Training p ro­
gram m es such as the STIP course coordinated 
by the Medical Society for the Study of Vene­
real Diseases (MSSVD) play a vital part in 
providing staff w ith  the education required to 
com petently extend their roles. The first Scot­
tish STIP course was ru n  in  Glasgow in M arch 
2002. The course was developed as a UK-wide 
initiative to support the im plem entation of 
the English national strategy for sexual health  
and HIV.'
In  order to evaluate the im pact attendance 
at the STIP course had on the knowledge of 
family p lanning staff, a prospective study was 
perform ed in  Glasgow. Eighteen m em bers of 
family p lanning staff (15 doctors and three 
nurses) were assessed on their knowledge of 
vaginal and cervical infections before and 
after attendance at the course, using four 
clinical case scenarios w ith accompanying 
clinical pictures. A m axim um  score of 12 was 
awarded for each assessm ent. The cases com ­
prised Candida, trichom onas, bacterial vagi­
nosis, and chlamydia. The participants were 
asked to provide a provisional diagnosis based 
on the history and a clinical picture. The vagi­
nal pH was th en  provided and each partici­
pan t was given the opportunity to alter their 
diagnosis in the light of this additional infor­
m ation. They were than  asked about the 
m anagem ent of each condition. W ithin 3
T able  1 The mean (SD), median precourse and post-course scores, and 
mean difference In scores
Precdurse score -
Post-course
Mean difference (95% Cl)
All participants (n=18)
Mean (SD) 8.2 (2.3) 10.7(1 .8) +2,5 (1.1 to 3.9)
Median 9.0 12.0
Doctors (n=15)
Mean (SD) 8.6 (1,9) 10.6 (1.8) +2.0 (0.7 to 3.3)
Median 9.0 12.0
Nurses |n=3)
Mean (SD) 6 .0  (3.0) 11 .0(1 .7) +5.0 (-3 .6  to 13.6)
Median 6.0 12.0
m onths of the  STIP course, each doctor and 
nurse w ere retested w ith the  initial scenarios. 
Answers and feedback w ere provided on com ­
pletion.
Two sample t tests and confidence intervals 
for the difference of two m eans were em ­
ployed to com pare all participants and the 
doctors and nurses scores before and after 
attendance at the STIP course. One sample / 
tests and confidence intervals for the differ­
ence of two m eans were employed to compare 
the doctors and nurses scores. As the num bers 
in  the study w ere sm all a subanalysis of the 
results for different grades of doctors was not 
perform ed. Table 1 shows the m ean (SD), 
m edian precourse and post-course scores, and 
m ean difference in scores. The m ean  increases 
in all participants' and the doctors' scores 
w ere statistically significant (p = 0.001, and p 
=  0.006, respectively). The m ean  increase in 
the nurses ' score w as 5.0 (95% Cl -3 .6  to 
13.6), however the num ber of nurse partici­
pants w as small (n = 3 ).
This study suggests th a t knowledge in ­
creased following attendance at the STIP 
course. Educational initiatives such as the 
STIP course are im portan t tools for develop­
m ent of staff working in the field of sexual
and reproductive health  care. A larger study of 
this type assessing a w ider range of subject 
m atter w ith  longer follow up would enable 
fu rther evaluation of the STIP courses' impact 
on knowledge.
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